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ABSTRACT
In presence of damage to nuclear DNA, eukaryotic cells trigger a set of signal transduction 
pathways, which lead to the arrest of cell-cycle progression until repair has occurred, to the 
increase of DNA repair capacity or, in some cases to a controlled suicide (apoptosis). In 
human cells in presence of DNA damage Chk2 kinase protein is activated by ATM, the 
protein mutated in ataxia telangiectasia (AT), and targets several substrates involved in the 
global DNA damage response.
I demonstrated that Chk2 activation after DNA damage induction by y-radiation treatment 
requires, besides ATM, Nbsl, the gene product involved in the Nijmegen Breakage 
Syndrome (NBS), a disorder that shares with AT chromosome fragility, radiosensitivity 
and radioresistant DNA synthesis. While in normal cells Chk2 undergoes a time-dependent 
increased phosphorylation and activation, in NBS cells these events are impaired. These 
defects can be complemented by the reintroduction of wild type copy of Nbsl gene, but not 
by a deletion mutant encoding for a protein unable to form a complex with M rell and 
Rad50 in the nucleus. These results underline the main role of Nbsl complex in ATM- 
Chk2 pathway in response to DNA damage and suggest that some defects in NBS and AT 
cells may result from defective Chk2 activation.
Since Nbsl and ATM are involved in DNA breaks resolution, I investigated the 
lesion specificity of Chk2 response. Normal lymphoblastoid cells were exposed to different 
DNA damaging agents and proteins modifications and activation were evaluated. I 
demonstrated that ATM and Chk2 respond respectively to a low (<3) and a higher (>19) 
amount of double strand breaks per cell. Furthermore Chk2 activation was detectable only 
in response to double strand breaks occurrence but not to single strand breaks or lesions 
induced by UV or hydroxyurea. These data underline the specificity and the different 
sensitivity of DNA damage response components.
INTRODUCTION
During their life eukaryotic cells are under the constant attack of endogenous and 
exogenous stress sources. Particularly the biochemical structure of genomic DNA is highly 
sensible to a great variety of genotoxic agents. The maintenance of genomic stability is 
essential for a cell to survive and transmit with fidelity the DNA content to the daughter 
cell; therefore during evolution cells have developed a sophisticated mechanism, in order 
to prevent loss of genetic information, mutagenesis or cell death.
1. CAUSES OF DNA LESIONS OCCURENCE
Life exposes humans and all organisms to the constant presence of chemicals, 
radiation, and other sources that can damage DNA (Figure 1). Nucleotide changes in 
genome DNA, named mutations, while fuelling evolution can be detrimental to the 
organism and hence must be repaired to prevent uncontrolled cell growth and cancer, or 
cell death. In general, two are the main sources of genomic DNA lesions in a cell: 
endogenous and exogenous genotoxic agents.
i) Endogenous sources:
DNA damage occurs at high frequency in a normal cell life, due to products of the
cellular metabolism (Barnes and Lindhal, 2004). These include reactive oxygen species
(superoxide anions, hydroxyl radicals and hydrogen peroxide) derived from oxidative 
respiration and products of lipid peroxidation. Over 100 different oxidative modifications 
have been identified in DNA (Cadet et al., 1997) and although cells have implemented a 
sophisticated antioxidant defense system, the rate of steady-state endogenous oxidative 
lesions in a mammalian cell has been estimated at 104-105 adducts per cell in mammals.
Spontaneous disintegration of chemical bonds in DNA is also present under physiological
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conditions, and base loss due to spontaneous hydrolysis of DNA glycosyl bonds is in the 
order of 104 events per day for a mammalian cell (Lindhal and Andersson, 1972).
Other spontaneous DNA lesions are alkylations, deaminations and replicational 
errors, this last occurring during normal DNA duplication, like base misincorporation 
errors and stalled replication forks (Loeb and Cheng, 1990).
ii) Exogenous sources: Environmental agents are the other major cause of DNA 
damage. The ultraviolet component of sunlight, ionizing radiation (IR) and numerous 
genotoxic chemicals affect daily eukaryotic cells (Figure 1).
UV light is a component of sunlight ranging in wavelength from 200 to 400 
nanometers (nm). This range is usually divided into three groups: UVA (320-400 nm); 
UVB (290-320 nm); UVC (200-290 nm). Most of the UV in sunlight never reaches the 
earth; in fact, as a result of atmosphere and ozone layer nearly no UVC and very little 
UVB, the shortest and most energy-packed UV wavelengths, reach the earth's surface. 
UVB rays penetrate the epidermis and, reaching keratinocytes, could induce DNA damage 
in these cells. The major lethal lesions produced are pyrimidine dimers as a result of a 
covalent attachment between adjacent pyrimidines in one strand (Cadet et al., 2005). These 
dimers, like bulky lesions from chemicals, block transcription and DNA replication and are 
lethal if unrepaired. They can stimulate mutation and chromosome rearrangement as well. 
UVA is already an important source of damage, because it comprises 95% of solar 
radiation, but in contrast to UVB the mutagenic potential of UVA is very limited and DNA 
damages could be induced by this wavelength only indirectly, because it is hardly absorbed 
by the DNA molecule.
Ionizing radiation was the first mutagenic agent described as its effects on genes were 
first reported in the 1920's. X- and gamma-rays are energetic enough to produce reactive 
ions (charged atoms or molecules) when they react with biological molecules; thus they are 
referred to as ionizing radiation. When a photon of radiation passes through a cell, the
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energy deposited excites an electron, which may either damage the DNA directly or 
indirectly through the mediation of hydroxyl radicals from water which can diffuse to the 
DNA and cause damage (Breen and Murphy, 1995). The most frequent lesions produced 
by radiation are base damages but, in contrast to other genotoxic agents, also DNA breaks 
are produced (Khanna and Jackson, 2001). According to the lower energy necessary to 
break a single DNA chain, most of the damage which occurs after y or x-irradiation of a 
cell leads to the generation of single strand DNA breaks (SSBs), which can be readily 
repaired using the opposite strand as a template. Occasionally, however, two breaks occur 
very close to each other on opposite strands, or directly opposite each other, which may 
result in a double strand break (DSB). Furthermore a part of SSBs and DSBs created by 
radiation are complex, because accompanied by additional base damage and therefore 
particularly difficult to be repaired. It has been estimated that in a mammalian cell 
radiation damage is comprised of approximately 40 DSBs, 1000 SSBs and 2700 base 
damages Gy'1 cell'1 (Ward, 1994).
In human body the rapidly dividing cell types (blood cell-forming areas of bone 
marrow, gastrointestinal tract lining) are the most affected ones by ionizing radiation and 
the severity of the effects depends upon the received dose. The information about the dose- 
effects relation in humans is based upon accidental exposures of nuclear plant workers and 
victims of atomic bomb explosions, such as those in Hiroshima and Nagasaki:
sublethal dose fl-2.5Gv): nausea and vomiting early; 1-2 wk. latent period followed 
by malaise, anorexia, diarrhea, hair loss, recovery (latency due to time it takes 
hematopoietic or other damage to show up)
lethal dose f3.5-4.5Gvh nausea and vomiting early; 1 wk. latent period followed by 
above with more severe symptoms including internal bleeding; a 50% chance of death 
(LD50 : dose at which half of exposed individuals will die; ca. 4Gy for humans). Death is 
due to blood cell or gastrointestinal failure
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suvralethal dose (>6.5Gv) : nausea and vomiting early, followed by shock, abdominal 
pain, diarrhea, fever and death within hours or days. Death is due to heart or central 
nervous system damage.
The studies about the effects of radiation are particularly relevant for human health, 
because cells are normally exposed to space radiation, but in addition human body could 
be exposed to IR during medical exam (i.e. tomography exam dose: 0.002-0.05Gy) and 
therapeutic treatments (i.e. therapeutic thyroid cancer treatment: dose to the thyroid 50- 
lOOGy, dose to the whole body 0.05-0.15Gy).
Finally there are many chemical damaging agents capable to stress DNA structure. 
Some well-known examples are: nitrous acid (formed by digestion of nitrites used as 
preservatives in foods that causes deaminations), nitrosoguanidine, methyl 
methanesulfonate, ethyl methanesulfonate (all react with bases and add methyl or ethyl 
groups), psoralens (found in some vegetables and used in treatments of some skin 
conditions agents causing intra- and inter-strand crosslinks), peroxides and genotoxic 
compounds in cigarette smoke.
Collectively, nuclear DNA suffers a large amount of damage per cell per hour as 
summarized in Table 1.
2. THE DNA DAMAGE RESPONSE
Nuclear DNA damage in eukaryotic cells triggers a set of signal transduction 
pathways, which are collectively known as “the DNA damage response” (Figure 2). Many 
are the final effects of the DNA damage response: one well-known feature is the slowing 
or arrest of cell-cycle progression, as a result of what are termed DNA damage 
checkpoints, which delay key cell-cycle transitions until repair has occurred (Li and Zou, 
2005). Other aspects of the DNA damage response include changes in chromatin structure
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at the site of damage, and the transcriptional induction and posttranslational modification 
of various proteins involved in increasing DNA repair capacity (Rouse and Jackson, 2002). 
Finally, in presence of a large amount of DNA damage, a cell of a multicellular organism 
could also trigger a highly regulated suicide, a process named “apoptosis”. In some cell 
types, instead of apoptosis, a stress induced premature senescence is in response to DNA 
damage (Wahl and Carr, 2001).
All these pathways are finely regulated and coordinated and could be rapidly turned 
on and off (Wang and Cho, 2004). Furthermore the same damaging lesion could activate 
different responses, if inferred in different moment of the cell cycle progression.
Considering the high rate of spontaneous damages present in normal cell, it's also 
conceivable that not every damage activates checkpoints. In some cases, the lesions may 
be relatively easy to repair and a quick reversion after initial detection may prevent 
initiation of a global DNA damage response.
The principal notions about the DNA damage response, with the exclusion of 
apoptosis, derive from studies in model organisms, particularly the budding yeast 
Saccharomyces cerevisiae, but it has been demonstrated that the DNA damage pathways 
are highly conserved during evolution.
2.1 DNA lesions detection
The first step that activated the DNA damage response is damage detection (Figure
2). The cell must be able to reveal many types of DNA lesions and very low levels of DNA 
damage anywhere in the genome. Studies in budding yeast have indicated that even a 
single persistent double strand break can be detected and, under some circumstances, can 
trigger a global DNA damage response (Sandell and Zakian, 1993). Therefore a single 
break, in a genome of 12 million base-pairs of DNA tightly packed into chromatin, can be 
efficiently detected. The rapidity and potency of the DNA damage response indicates the 
high sensitivity of signaling proteins involved and their capacity to greatly amplify the
initial stimulus (McGowan and Russell, 2004).
2.2 Cell cycle arrest
The normal eukaryotic cell cycle is separated into four different phases. The two 
key events of the cell division cycle are: S-phase, in which the entire genome is replicated, 
and mitosis (M-phase), where the chromosomes are segregated into two daughter cells, 
which separate at cytokinesis. Between the end of M and the beginning of S phase there is 
an interval, known as G1 (G=gap); a second interval, known as G2, separates the end of 
DNA synthesis from the beginning of the next M-phase. This linear description of the cell 
cycle, however, is not always obeyed and some differentiated cells exit the cell cycle into a 
quiescent phase known as Go.
In proliferating cells, an adequate response to the presence of a significant amount of 
DNA damage requires more than repair of the DNA lesions. The threat posed by damage is 
particularly serious during the two major cell cycle events: DNA replication and mitosis. 
Replication can render mutations irreparable, while mitosis in presence of unrepaired 
strand breaks can lead to gross chromosomal aberrations in the daughter nucleus. In order 
to counter these threats to genomic integrity, eukaryotes employ mechanisms that arrest the 
cell cycle temporarily in order, to allow the time to repair the damage. These regulatory 
mechanisms, that do not allow the initiation of a new phase of the cell cycle until the 
damage is repaired, are named “checkpoints” (Figure 2). Specific checkpoints control G l- 
S, G2-M boundaries and different stages of the S phase. While G1 and G2 progressions 
could be completely arrested until cells have repaired the damage, S phase could only slow 
down to avoid that the structures present on replicating DNA stall and therefore collapse, 
creating a more severe situation.
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2.3 DNA repair
All cells possess a large number of different types of repair system, each relatively 
specific for a certain type of DNA damage (for a review see Yu et al., 1999; Figure 1).
Base modifications are corrected by Direct Reversal of Base Damage without the 
need to break the DNA backbone, while non-bulky damage to bases resulting from 
oxidation, methylation, deamination, or spontaneous loss of the DNA base and single 
strand breaks are corrected by Base Excision Repair (BER) through the cleavage of the 
DNA backbone.
Nucleotide Excision Repair (NER) is perhaps the most flexible of the DNA repair 
pathways, considering the diversity of DNA lesions it acts upon (mainly pyrimidine 
dimmers, but also bulky chemical adducts, DNA intrastrand crosslinks and some forms of 
oxidative damage). The common features of NER processed lesions are that they cause 
both a helical distortion of the DNA duplex and a modification of the DNA chemistry. 
NER system differs from BER because, even though in presence of only a single incorrect 
base, this nucleotide is removed along with many other adjacent ones, creating a large gap 
around the damage. The importance of NER pathway is underlined by the occurrence of 
two rare autosomal recessive disorders, characterized by various degree of photosensitivity 
(even to enhanced skin cancer predisposition) and associated with defects in some NER 
components: xeroderma pigmentosum (XP) and the Cockayne's syndrome (CS). Finally, 
Mismatch repair (MMR) corrects replication mistakes, such as base-base mismatches and 
insertion/deletion loops.
Among the many types of DNA damage that exist within the cell, double-strand 
breaks (DSBs) are probably the most dangerous ones, because free DNA ends are 
subjected to degradation, but also extremely reactive. Furthermore DSBs differ from most 
other types of DNA lesions and are intrinsically more difficult to eliminate, because they 
affect both strands of the DNA duplex and therefore they prevent the use of the 
complementary strand as a template for repair.
DSBs lesions should result from exogenous agents (ionizing radiation, 
chemotherapeutic drugs...), but also from endogenously generated reactive oxygen species 
or mechanical stress on the chromosomes. They can also be produced as secondary 
damages, when DNA replication forks encounter DNA single-strand breaks or other types 
of lesion (Vilenchik and Knudson, 2003) and they can also occur at the termini of 
chromosomes, due to defect in the metabolism of chromosome ends (telomeres). In 
addition, regulated DSBs are generated during meiotic recombination and during regulated 
rearrangements, such as V(D)J recombination and immunoglobulin class-switch.
Endogenous, regulated or spontaneous, and exogenous DSBs seem resolved by the 
same pathways. Erroneous rejoining of broken DNA DSBs are particularly mutagenic 
events, leading to the loss, amplification or translocation of chromosomal material. All 
these events can lead to tumorigenesis if stroke chromosomal region encoding a tumor 
suppressor or proto-oncogenes. In order to counteract the detrimental effects of DSBs, cells 
have evolved two distinct and complementary mechanisms to repair these lesions: 
homologous recombination (HR) and non-homologous end-joining (NHEJ).
HR-directed repair (Khanna and Jackson, 2001) corrects DSB defects in an error-free 
manner, using a mechanism that retrieves genetic information from a homologous, 
undamaged DNA duplex; for these characteristics is confined to act only in presence of a 
sister chromatid and therefore in S, G2 or M phase of the cell cycle. In contrast, for NHEJ 
an undamaged partner is not necessary and the two ends are ligated together, but 
sometimes this occurs after limited DNA degradation at the termini. Consequently, NHEJ 
is often prone to error, and small sequence deletions are usually introduced (Lieber et al., 
2003).
A so wide and specific set of responses allows eukaryotic cells to repair all kind of 
damages at very high rates and efficiencies as summarized in Table 2.
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2.4 Apoptosis
In multicellular organisms, in presence of damage beyond repair, as an alternative 
and ultimate strategy for preventing the propagation of a mutated genome, cells could 
induce a programmed cell death, a mechanism named “apoptosis” (Norbury and 
Zhivotovsky, 2004).
Apoptosis is a highly conserved physiological form of cell suicide, which occurs 
normally in some cell types and is required in normal development and for the 
maintenance of tissue homeostasis (reviewed by Kerr et al., (1994)). Programmed cell 
death is a highly regulated series of events, which can be distinguished from degenerative 
cell death or necrosis by morphological and biochemical criteria. During apoptosis the 
activation of a signal transduction cascade conducts to genomic DNA degradation: the 
nucleus shrinks and becomes pyknotic; fragments of nucleus and cytoplasm are pinched 
off as nuclear blebs, resulting in progressive shrinkage of cell size. These fragments are 
engulfed by macrophage, but they do not elicit the synthesis of inflammatory cytokines and 
therefore, in contrast to cell necrosis, do not activate an inflammatory response. Apoptosis 
is activated in response to different forms of physiological, pathogenic or cytotoxic stress. 
In response to DNA damage this machinery is essential, because it protects the organism at 
the expense of the individual cell.
2.5 Cell cycle arrest, senescence or suicide?
The p53 tumor suppressor protein plays a key role in the regulation of the cell cycle 
and cell death (Meek, 2004), other than in cell differentiation, DNA repair, senescence and 
angiogenesis. A Wild type (wt) p53 is essential for the prevention of cancer (Sharpless and 
DePinho, 2002), consistent with the high tumor incidence observed in p53 null mice and in 
the p53 heterozygosity, detectable in patients affected by the cancer prone Li-Fraumeni 
syndrome. It is estimated that approximately one half of human cancers contains a 
mutation in p53 and that in the majority of the remaining tumors the p53 signaling pathway
is inactivated by up-regulation of p53 inhibitors, such as Mdm2 and MdmX, or by down- 
regulation of p53 cooperators, such as ARF. This increased predisposition to tumor 
development in the absence of a functional p53 pathway is mainly due to the accumulation 
of genetic alterations and failure to eliminate these defective cells.
Wild type p53 is a labile protein with a short half-life, but accumulation and 
activation of the protein (Figure 3) can be triggered by a variety of stress signals, including 
DNA damage, hypoxia, nucleotide deprivation, viral infection, heat shock and mitogenic 
or oncogenic activation (Appella and Anderson, 2001). The specific activity of p53 is 
enhanced by post-translational modifications (Appella and Anderson, 2001) and by a wide 
spectrum of positive and negative regulators, ultimately leading to growth arrest and/or 
apoptosis (Figure 3). In normal non-stressed cells, the p53 protein level is very low and 
this is due to an autoregulatory feedback-loop mechanism in which the Mdm2 and MdmX 
proteins play a key role (Figure 3). Mdm2 interacts with p53 and this has two effects: first, 
the binding of Mdm2 to p53 may interfere with the interaction of p53 with the transcription 
machinery and second, Mdm2 can act as an ubiquitin E3 ligase on p53 and target it for 
degradation by the proteasome. MdmX, on the contrary, retains only the ability to interact 
and inhibit p53 transactivation activity, but could also be captured and degraded by Mdm2 
(Marine and Jochemsen, 2004). If cells are subjected to a DNA-damaging agent, certain 
kinases such as DNA-PK, ATM, ATR or Chk2 may be activated and induce 
phosphorylation events on specific residues of p53, Mdm2 and MdmX in such a way that 
the effects of Mdm2 and MdmX on p53 may be impaired (Figure 3). The final effect of a 
p53 protein is accumulation and activation (Appella and Anderson, 2001). DNA damage 
inducing pro apoptotic transcriptional targets of p53 are Bax, Killer/DR5, p53RDLl, Bak, 
Puma, Noxa, PIG, Bid and, on the contrary p53 dependent cell cycle arrest inducers are 
p21wafl, Rb, GADD45, p53R2 and Reprimo (for rewievs see El-Dehiry, 2003 and Fei and 
El-Dehiry, 2003).
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The choice between growing arrest and apoptosis is determined mainly by 
characteristics and amount of the lesions. Specifically, for IR, the intensity of DNA 
damage appears to be an important determinant: lower doses of IR inducing reversible cell 
growth arrest (Kastan et a l, 1991) and higher doses of IR trigger apoptosis. This is 
obtained through the phosphorylation of different sets of p53 residues, according to the 
dose of damage. All these modifications ultimately differently affect the outcome of p53 
response, because p53 binds to its responsive promoters with different affinity, due to 
sequence heterogeneity among the various responsive elements and the sequence specific 
DNA binding can be affected by changes in p53 conformation and by the conformation of 
cognate DNA sequences. An example of how different lesions could give rise to different 
cellular response is described by UV radiation and IR treatments. For instance, the 
osteosarcoma U20S cells undergo apoptosis in response to UV, but undergo growth arrest 
upon IR. The accumulation of p53 in response to IR is rapid and transient, whereas in 
response to UV it is slow, intense and persists for long period. These differences can be 
explained, at least in part, by the different kinetics by which double strand breaks (DSB) 
versus bulky adducts are being repaired. The nucleotide excision repair (following UV) is 
slower than the DSB repair (following IR). Moreover, UV and IR trigger different signal 
transduction pathways, which ultimately lead to different pattern of post-translational 
modifications of p53, reflecting differential activation of upstream kinases. ATM is the 
critical upstream effector of p53 after IR, whereas p38 is essential for the UV-induced p53 
activation, ATR and DNA-PK phosphorylate p53, following both signals.
The importance of DNA lesions amount and characteristics on the choice of outcome 
underlines that cell fate may be determined early when the damage is introduced, with p53 
possibly integrating a plethora of signals. The signal imposed by DNA damage could be 
influenced by a variety of extracellular and intracellular conditions; an important role is 
recovered by the cell type (i.e. lymphocyte and fibroblast), by the presence of deregulated
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expression of oncogene (i.e. in tumor cells) and by growth and survival factors (i.e. 
cytokines).
While the main cellular response to DNA damage is cell death or reversible cell- 
cycle arrest, in some circumstances, depending on the type of agent, the dosage 
administered and the type of cell treated, senescence could also occur (Wahl and Carr, 
2001). This “premature senescence”, both in the tissue culture and in the living mouse, can 
usually be prevented by p53 inactivation (Ongusaha et al., 2003). It is not clear how cells 
choose between senescence and apoptosis upon DNA damage-induced p53 activation, but 
also in this case it has been suggested a role for p53 post-translational modifications 
(Webley et al., 2000), interactions and the activation of different sets of transcriptional 
targets (Wahl and Carr, 2001). It is known that normal cells, in which all signaling 
pathways are intact, have a preference toward senescence when compared to transformed 
cells, and that senescence is usually induced by lower levels of DNA damage than those 
leading to apoptosis (Ben-Porath and Weinberg, 2005). The importance of the DNA 
damage response in senescence is also underlined by evidences that common proteins (i.e. 
y-H2AX, Mdcl, Nbsl, ATM, Chk2, p53) are involved in the classical telomere-uncapping 
senescence (D’Adda di Fagagna et al., 2003), but also after oncogene expression induced 
senescence (Serrano et al., 1997).
2.6 DNA damage response defects: genomic instability and cancer
Left unrepaired, the myriad types of damage that can occur in genomic DNA could 
not only induce acute effects like transcription block or disturbed DNA metabolism and 
replication, but could also pose a serious threat to the faithful transmission of the genetic 
material. Over time, DNA accumulates changes that activate proto-oncogenes and 
inactivate tumor-suppressor genes. Therefore the genetic instability driving tumorigenesis 
is fuelled by DNA damage and by errors made by the DNA machinery (Lavin et al., 2005), 
in addition to inherited faulty genome guardians that cause a mutator phenotype. Genome
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instability is one of the main forces driving the onset and progression of carcinogenesis 
(Lavin et al., 2005). Genetic degeneration is linked intimately with all aspects of 
maintenance of DNA integrity and gene function and is fuelled by the continuous erosion 
of the genome by environmental and endogenous genotoxic agents.
For some kind of tumors a ’’route to cancer” has been established; for example the 
number of genetic alterations required for a normal cell to progress to an invasive 
metastatic tumor varies from as many as 7, in the case of stomach cancer, to around 12 in 
the case of colorectal cancer (Renan, 1993). What emerges clearly is that a high number of 
mutations is necessary to create a tumor cell, while the spontaneous mutation rates in 
normal human cells cannot account for them. Therefore genomic instability, defined as all 
mechanisms that accelerate the accumulation of damage or modifications to DNA, has 
been proposed as an important process which contributes to the heterogeneity and 
progression of tumors. In particular the importance of cell cycle checkpoints in genomic 
stability (Hartwell and Kastan, 1994) is underlined by the observation that many inherited 
syndromes characterized by chromosomal instability and predisposition to malignancy 
(Kastan and Bartek, 2004), also possess defects in cell cycle regulation. As for instance all 
the major Gl/S checkpoint transducers and effectors, with the exception of ATR, whose 
lack causes early embryonic lethality in mice and whose somatic defects might result in 
cell death, qualify as either tumor suppressors or proto-oncogenes, and their loss-of- 
function mutations or over-expression have been identified in many types of human 
malignancies. Hereditary mutations in at least ATM, Chk2, BRCA1, M rell, Nbsl, p53, 
p i6, and RB and other DNA damage involved gene are known to cause familial cancer 
and/or cancer prone clinical syndromes (Vessey et a l, 1999; Dasika et al., 1999; Kastan 
and Bartek, 2004). The intimate involvement of cell-cycle checkpoints in molecular 
pathogenesis of cancer justifies the importance to explore this field in order to employ 
knowledge for diagnostic purposes and chemotherapy or radiotherapy treatment strategies.
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3. ATAXIA TELANGIECTASIA, NIJMEGEN BREAKAGE SYNDROME AND
ATAXIA TELANGIECTASIA LIKE SYNDROMES
3.1 Ataxia Telangiectasia
Ataxia Telangiectasia (AT) is an autosomal recessive disorder with a prevalence of 
1/40,000 to 1/100,000 live births, characterized by early-onset cerebellar ataxia as its 
defining neurologic feature (for a review see McKinnon, 2004) (Table 3). Progressive 
cerebellar ataxia degeneration of Purkinje cells is almost always the presenting symptom 
and becomes apparent as early as the first year of life as increasing clumsiness and balance 
problems. By age 10 to 12, children with AT loose muscle control leading to wheelchair 
dependence by the second decade. As symptoms become progressively worse, speech 
becomes slurred and difficult. Telangiectases appear an average of two to four years after 
onset of the neurologic syndrome and are progressive. They are composed by dilated 
capillaries in the conjunctiva and later also on the ears, cheeks and nose. Other 
accompanying extra-neural features include elevated levels of serum alpha-fetoprotein, 
chromosome aberrations, immunodeficiency with recurrent sinopulmonary infection, 
cancer susceptibility, radiation hypersensitivity and endocrine disorders, such as insulin- 
resistant diabetes mellitus. During their lives, nearly 40% of AT patients will develop a 
malignancy (Morrell et al., 1986) and about 85% of these malignancies will be leukemia or 
lymphoma. AT patients with cancer, treated with conventional doses of radiation therapy, 
result in devastating necrosis of normal tissues, demonstrating the high radiation sensitivity 
in these patients. The thymic hypoplasia with moderate cellular and humoral 
immunodeficiency is characterized by low levels of certain immunoglobulin classes (IgA, 
IgE, and IgG2), and T-cell deficiencies lead to frequent pulmonary infections in AT 
patients. The mean age of death is approximately in early or middle adolescence (about 17 
years old), usually caused by bronchopulmonary infection, less frequently by malignancy, 
or the combination of both. In the absence of chronic bronchopulmonary disease and
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lymphoreticular malignancy, AT is consistent with survival into the fifth or sixth decade of 
life.
Telomere shortening and fusions have been observed in peripheral blood 
lymphocytes of AT patients and in combination with the enhanced oxidative stress should 
also be responsible for progeroid features (gray hair or keratoses).
Mutations in the ATM gene are responsible for AT occurrence (Lavin and Khanna, 
1999). At this moment ATM mutations have been described in more than 300 AT families: 
most of the patients are compound heterozygotes and, in many populations, there is a 
strong founder effect, but mutations are widely distributed and no hot spot has been 
identified. Currently, about 70% of the ATM mutations identified result in premature 
protein truncations, but there are also about 30% missense mutations and small in-frame 
deletions/insertions.
The carrier frequency for ATM is estimated at 1%, heterozygous carriers are normal 
neurologically, although they have in vitro radiosensitivity values that are intermediate 
between homozygotes and normals (Smilenov et al., 2001). Several authors have reported 
that the incidence of cancer in AT heterozygotes is higher than the one in the general 
population, most notably breast cancer, but this is still controversial (Thompson et al., 
2005).
3.2 ATM
In order to identify the genetic defect responsible for ataxia telangiectasia 
multifaceted disorder, a genetic linkage analysis was performed mapping the AT-mutated 
(ATM) gene to chromosomal region llq22-23, and finally the ATM gene, identified as a 
PI-3 kinase related protein (Savitsky et al., 1995). The PI-3 kinase family of proteins 
(PIKKs) is characterized by a domain with motifs that are typical of the lipid kinase 
phosphatidylinositol 3-kinase (Figure 4) but, despite this sequence similarity, the catalytic 
domains of the PIKKs appear to transfer phosphate exclusively to protein, rather than lipid
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substrates, and most of them possesses a specific serine/threonine kinase activity (for a 
review see Abraham, 2004). The mammalian members of this family, at present, include 
five protein kinases: ATM, ATR, ATX/SMG-1, mTOR/FRAP, DNA-PKcs and TRRAP, 
which is a component of histone acetyltransferase complexes. Four mammalian PI-3 
kinases are known to be involved in the DNA-damage response: the DNA-dependent 
protein kinase (DNA-PK), ATM, ATR and ATX. ATM gene spans about 150 kilobases of 
genomic DNA, has 66 exons and is expressed in a wide range of tissues. The gene encodes 
a 350-kd (3056 amino acids) protein, in which the kinase domain represents less than 10% 
of the total ATM protein (Figure 4). Few other domains have been identified in ATM 
protein (Abraham et a l , 2001): a leucine zipper consensus sequence in the N terminus 
(until now there is no clear evidence that this motif is responsible for interaction of ATM 
with itself or with other proteins), and a proline-rich region that is a site for interaction with 
c-Abl, the non-receptor protein tyrosine kinase that has been implicated in processes of cell 
differentiation, cell division, cell adhesion, and stress response. ATM is localized mostly to 
the nucleus and has been shown to associate with DNA, with particular affinity for DNA 
ends (Abraham et al., 2001), but is also found in cytoplasmic vesicles (Gately et al., 1998). 
ATM kinase phosphorylates preferentially serine or threonine followed by glutamine 
(SQ/TQ), a sequence specificity shared with another PI-3 kinase, ATR. ATM and ATR 
both play a central role in the DNA damage response and appear to phosphorylate many of 
the same cellular substrates (for reviews see Tibbetts et a l, 2000; Zhou and Elledge, 2000; 
Khanna et a l, 2001; Rouse and Jackson, 2002). These kinases are activated by different 
forms of DNA damage and with different kinetics: ATM responds preferentially and 
rapidly to DNA double-strand breaks (DSBs) and therefore after treatments with ionizing 
radiation. On the contrary ATR functions following exposure to other forms of DNA 
damage, such as bulky lesions or stalled replication forks and therefore treatments with UV 
or hydroxyurea (O'Connell et a l, 2000; Khanna et a l, 2001) and only with a slow kinetics 
to radiation. In contrast to ATM, ATR is an essential gene required for cell proliferation
and in ATR null mice it causes early embryonic lethality (Brown and Baltimore, 2000); for 
this reason ATR is less studied and characterized. The yeast homologue of ATM is Tell in 
both Saccharomyces cerevisiae and Schizosaccharomyces pombe, while ATR is the 
sequence and functional homologue of S. pombe Rad3 and S. cerevisiae Mecl. In both 
yeasts, Tell plays only a minor role in signaling the presence of DSBs, while Mecl- or 
Rad3-dependent pathways respond to all forms of DNA damage, underlining significant 
differences besides a general functional and structural conservation between yeasts and 
mammals cells.
The mechanisms for ATM activation in presence of DNA damage have been almost 
in part elucidated (Bakkenist and Kastan, 2003). In normally growing cells ATM is in a 
dimeric insoluble inactive form, but after the occurrence of DSBs, probably as a 
consequence of chromatin remodeling events, ATM autophosphorylates in Serine 1981 
residue, becoming monomeric, soluble and active towards substrates (Figure 5). Up to now 
it’s not clear if ATM is the primary and direct sensor of damage, or a mediator between the 
lesion and ATM is necessary to induce ATM autophosphorylation.
The number of ATM substrates and ATM-dependent events is wide and rapidly 
increasing. Many substrates are directly or indirectly involved in many aspects of the 
global DNA damage response (Figure 5) among them are: p53, Mdm2, MdmX, Chk2, 
53BP1, Nbsl, M rell, Brcal, H2AX, Mdcl, Smcl, FANCD2 and others, underlining the 
pivotal role of ATM in this field.
3.3 Nijmegen breakage syndrome
Nijmegen breakage syndrome is a rare inherited autosomal recessive disease (Table
3) originated in central Europe, in the Slavic population, and spread through a founder 
effect (Cerosaletti et al., 1998; Varon et al., 2000). More than 130 cases have been 
identified worldwide, including 68 in Poland and 26 in the Czech Republic. NBS shares a 
number of cellular features with AT, in particular a specific sensitivity to ionizing radiation
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and radiomimetic chemicals. As a result, NBS has often been described as a variant of AT 
(Saar et al., 1997). However, NBS patients lack many of the clinical hallmarks of AT such 
as progressive cerebellar ataxia, oculocutaneous telangiectasia and elevated serum alpha- 
fetoprotein levels. Clinically (Digweed and Sperling, 2004), NBS is characterized by 
microcephaly, a distinctive facial appearance described as “bird-like”, growth retardation, 
immunodeficiency, frequent sino-pulmonary infections, chromosomal instability, radiation 
hypersensitivity and an increased incidence of malignancies, particularly lymphomas. 
Other manifestations are impaired sexual maturation in females, skeletal defects, urogenital 
malformations and skin pigmentation abnormalities. Intellectual abilities tend to decline 
over time and most children tested after the age of seven years have mild-to-moderate 
mental retardation. Immunodeficiency is usually characterized by defects in both cellular 
and humoral compartments. Due to defective immunity most, but not all NBS patients, 
show frequent respiratory, gastrointestinal and urinary infections. Constitutional 
karyotypes of NBS patients are generally normal, but cytogenetic aberrations are observed 
in 10-45% of metaphases from cultured T cells. As in AT, the vast majority of 
chromosome aberrations involve chromosomes 7 and 14. Typical and specific are 
inversions and translocations with breakpoints at the sites of immunoglobulin or T cell 
receptor genes. Malignancies occur at an elevated frequency and at an early age in NBS 
patients (mean age 9 years) and are almost exclusively lymphomas more often involving 
B-cells, in contrast with those found in AT. On the basis of available records, a 50-fold risk 
of early-onset cancer and a greater than 1000-fold risk of lymphoma are estimated for 
patients with NBS. Malignancy is the most common cause of death in infancy in patients 
with NBS; besides, a small number of patients died for bronchopneumonia. A polish 
patient 33 years aged is the longest survival known.
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3.4 Nibrin (NBS1)
NBS disease is caused by defect in nibrin (NBS1) gene located in chromosome 8 
(Varon et al., 1998), coding for a 95KDa protein with 754 amino acids (Figure 4). Nibrin 
contains in the N-terminal a forkhead associated domain (amino acids 24-100) and a breast 
cancer domain (BRCT; amino acids 105-190) (Figure 4). Both domains are found in the 
various DNA damage responsive cell cycle checkpoint proteins and are involved in 
phosphoproteins interaction. Identified as the p95 subunit of the Mrell/Rad50/Nbsl 
double-strand DNA break repair complex (Carney et a l, 1998; Trujillo et al., 1998), nibrin 
is responsible for the nuclear localization and for the redistribution of the complex in foci 
(Tauchi et al., 2001; Desai-Mehta et al., 2001), associated with DSBs (Figure 6). 
Furthermore Nbsl is essential for the nucleolytic activities of this complex, which is an 
essential step in NHEJ repair of DSBs. Nbsl regulates the activities of the complex and is 
targeted by signaling pathways that initiate DNA damage-induced checkpoint responses 
(Figure 6). The Mrell/Rad50/Nbsl complex shows also a role in meiotic recombination 
(Borde et al., 2004) and telomeres maintenance. In more than 90% of patients tested so far, 
the common 657del5 mutation of Slavic origin is present in homozygosity. This mutation 
leads to a premature stop codon with a truncation at amino acid 219. The truncated protein 
(26KDa) and a 70Kda protein, produced by internal translation initiation within the NBS1 
mRNA, using an open reading frame generated by the 657del5 frameshift, are detectable 
in NBS patients (Maser et a l, 2001). These two forms of truncated protein demonstrate 
that the NBS1 657del5 mutation is a hypomorphic defect and this could explain why Nbsl- 
null mouse are unviable (Zhu et a l, 2001). The remaining patients have a heterozygous 
657del5 deletion and a second unique mutation or a homozygous unique mutation, in any 
case leading to a hypomorphic defect of Nbsl protein.
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3.5 Ataxia telangiectasia like disease
The cases of two cousins with the same clinical and cellular features of ataxia 
telangiectasia, but with a milder clinical course, were reported some years ago (Stewart et 
al., 1999). In these two patients and in two other previously described ones, no ATM 
mutations were identified, while mutations in the MRE11 gene were revealed; therefore 
the new disease was named ATLD, for AT-like disorder (Table 3). Among the four 
patients two are homozygotes for a nonsense mutation at codon 633, and two compound 
heterozygotes for a null mutation and a substitution of serine for asparagine at amino acid 
117. Both the nonsense and missense mutated genes produce stable protein products that 
are able to associate with Rad50 and Nbsl, although the re-localization of the full complex 
at DSB sites is abnormal (Stewart et al., 1999). Data from m M rell knockout mice indicate 
that these human mutations are most likely partially functional, because a null allele of 
mM rell is lethal during embryogenesis (Xiao and Weaver, 1997), so as null alleles for 
mRad50 (Luo et al., 1999). Two cases of ATLD were described in Italy (Delia et al., 2004) 
and 10 in Saudi Arabia (Fernet et al., 2005).
3.6 M rell
Orthologues of the DNA double-strand break repair nuclease Mrel 1 and the ATPase 
Rad50 exist in all organisms. Mrell/Rad50 complex from bacteria is capable of tethering 
DNA ends and possesses a large spectrum of DNA nuclease, helicase, ATPase and 
annealing activities (Connelly and Leach, 2002). M rell and Rad50 mutations in mice 
showed a severe effect on embryonic viability, revealing the requirement for M rell 
complex functions in early embryogenesis (Xiao and Weaver, 1997; Luo et al., 1999). As 
described above, in eukaryotes the Mrell/Rad50 complex, in some circumstances, 
contains a third component, named Xrs2 in yeast and Nbsl in vertebrates (M/R/N 
complex). Sedimentation equilibrium analysis of the recombinant human complexes 
indicates that M/R/N form large multimeric assemblies of approximately 1.2 MDa (Lee et
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al., 2003). The minimal essential region for the interaction of M rell with Nbsl was 
described in the C-terminus of M rell protein (Figure 4; Tauchi et al., 2001). The human 
M/R/N complex is involved in meiotic recombination, homologous recombination, 
telomeres maintenance, DNA replication surveillance and DNA damaged structure 
detection and repair (D’Amours and Jackson, 2002). Particularly in DSBs the complex 
seems to enhance breaks repair holding DNA ends together in order, to ensure that they are 
coordinately and correctly rejoined (Figure 6 ). The ability of M rell to bind DNA was 
confirmed by the presence in this protein of two DNA binding motifs (Figure 4). 
Furthermore the complex could process DNA ends to make them accessible to subsequent 
reactions and could trap other DNA molecules, when necessary (i.e. during HR).
4. CHK2 KINASE PROTEIN
As previously described, Chk2 demonstrates an important role as signal transducer 
and particularly as a crucial link between the ATM/ATR kinases and downstream 
checkpoint effectors.
4.1 Chk2 homologs
The first member of the “Chk2 family” identified was Rad53 in budding yeast 
Saccharomyces cerevisiae and was described as a kinase involved in many checkpoint 
responses. Homologues of Rad53 were subsequently revealed in the fission yeast 
Schizosaccharomyces pombe, named Cdsl, and in higher eukaryotes, while the 
identification of the human homologue was reported by two laboratories in 1998/1999 
(Matsuoka et al., 1998; Chaturvedi et al., 1999). The main structure of the Chk2 proteins is 
conserved in all eukaryotes and the degree of homology is high and in accordance with the 
degree of evolution. Human CHK2 shows 83% and 82% amino-acid identity with the rat 
and mouse kinases: respectively, 61% identity with the Xenopus laevis protein; 51% with
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the zebrafish; 34% with Drosophila melanogaster; 32% with both S. pombe and the 
nematode Caenorhabditis elegans; 28% with S. cerevisiae Rad53. In particular Rad53 
differs from Chk2 for the presence, at carboxy terminus, of a second forkhead-associated 
(FHA) domain. Beyond the structural conservation, also the general role as transducers of 
cell cycle checkpoint signals is maintained throughout the evolution, although slight but 
significant functional differences between the members of the Chk2 family emerge, for 
example in lesion specificity or for the role in meiosis (Higashitani et al., 2000). On the 
other hand, the human CHK2 gene complements the checkpoint defects in both budding 
and fission yeast strains that are deficient in its homolog, thus underscoring an overall 
functional conservation among the Chk2 family members.
4.2 Chk2 gene and protein structures
The human CHK2 gene spans 50 kilobases of genomic DNA, containing 14 exons 
and encodes a kinase protein that is characterized by some evolutionarily conserved 
elements (Figure 4, Bartek and Lukas, 2001). At the amino-terminal is present a series of 
seven serine or threonine residues followed by glutamine (SQ or TQ motifs); these are 
known to be favorable sites for phosphorylation by upstream kinases as ATM/ATR kinases 
and their homologues (Figure 4). Among these residues Thr6 8  in humans seems to display 
an essential role in Chk2 activation after DNA damage (Melchionna et al., 2000). Another 
important region in Chk2 protein is the Fork Head Associated Domain (FHA) located 
between amino-acid residues 115 and 175 (Figure 4). This domain was identified in some 
transcription factors and in a range of mainly nuclear proteins with different functions. 
FHA domains seem necessary to bind phosphorylated residues and create protein-protein 
interaction (Durocher and Jackson, 2002), therefore is appears a good candidate for 
dynamic interactions of Chk2 with its upstream regulators and/or downstream targets in 
cell-cycle-checkpoint signaling. Finally the kinase domain occupies a large region in the
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carboxy-terminal of Chk2, with its highly conserved functional elements, including the 
activation loop.
4.3 Chk2 protein activation
In order to describe Chk2 activation in humans, one model was proposed that seems 
to well resume the data until now obtained in higher eukaryotes (Figure 7). The first step is 
carried out by the ATM kinase, in response to double-stranded DNA breaks. This initial 
wave of phosphorylation targets serines or threonines in the regulatory SQ/TQ-rich domain 
of human Chk2 and particularly the residue Thr6 8  (Matsuoka et al., 2000; Ahn et al., 
2000; Figure 7). The phosphorylation at Thr6 8  is a prerequisite for the dimerization of two 
Chk2 that is mediated by the interaction of the phosphorylated SQ/TQ domain of one 
molecule and the FHA domain of the other Chk2 protein (Ahn et al., 2002; Figure 7). The 
final activating step is attributable to an in trans autophosphorylation of Chk2 on residues 
Thr383 and Thr387 in the activation loop of the kinase domain (Schwarz et al., 2003; 
Figure 7). The initial phosphorylation in the SQ/TQ-rich domain might also evoke a 
conformational change in Chk2 that exposes the activation loop of the kinase and thereby 
facilitates its full activation. For the autophosphorylation step the presence of an FHA 
domain is also essential, which could be involved not only in Chk2 dimerization, but might 
also mediate the interaction of Chk2 with other checkpoint regulators. This mechanism of 
activation for Chk2 clearly resumes the basic characteristic of the kinase cascades involved 
in DNA damage signaling: a strictly regulated amplification of the initial signal. In fact a 
Thr6 8  phosphorylated Chk2 could activate others unmodified Chk2 molecules, by 
targeting the sites in the kinase domain. T6 8  phosphorylation is also essential for the 
relocalization of Chk2 in structures that appear as spot on DNA in an immunofluorescence 
analysis with a phosphospecific antibody (Ward et al., 2001).
A role in Chk2 activation has been described also for two proteins, NFBDl/Mdcl 
(Peng and Chen, 2003) and 53BP1 (Wang et al., 2002), that are rapidly recruited at sites of
DNA damage (evaluated through the formation of foci by immunofluorescence techniques) 
and that seems to affect Thr6 8  phosphorylation and Chk2 redistribution at damage sites, as 
described in some reports (Ward et al., 2001).
4.4 Chk2 functions
After the activation Chk2 propagates the DNA damage signal along several 
pathways, which causes cell-cycle arrest in the G l, S and G2/M phases, activation of DNA 
repair and, in some cases, apoptotic cell death or premature senescence (Figure 8 ).
Chk2 seems to impose a Gl/S arrest through different effectors. Particularly Ser20 in 
p53 (Shieh et al., 2000), Ser394 in E2F-1 (Rogoff et al., 2004) and Seri23 in Cdc25A 
(Falck et al., 2001) were described as potential Chk2 targets (Figure 8 ). These 
phosphorylation events seem to induce respectively p53 accumulation (Hirao et al., 2000; 
Chehab et al., 2000), E2F-1 activation (Stevens et al., 2003) and Cdc25A degradation 
(Falck et al., 2001), all events that contribute to a Gl-S and S (only demonstrated for 
Cdc25A) progression block. In other papers the role for Chk2 in p53 accumulation has 
been questioned (Ahn et al., 2003) and the essentiality for Cdc25A degradation partially 
revised. Particularly, more than in p53 stabilization Chk2 seems involved in activation of 
p53 and in induction of specific p53-dependent transcriptional targets like p21wafl (Hirao et 
al., 2000). Therefore the phosphorylation of Ser20, a residue in Mdm2 interaction domain 
of p53, by Chk2 seems improbable. Another possible explanation for the role of Chk2 on 
p53 modulation is suggested by the ability of Chk2 to phosphorylated MdmX (Chen et al., 
2005). Indeed, after DNA damage MdmX protein is phosphorylated by Chk2 on Ser342 
and Ser367 residues, thus stimulating MdmX interaction with 14-3-3 protein. This binding 
induces MdmX nuclear translocation, ubiquitination and degradation in an Mdm2- 
dependent way. The reduced level of MdmX protein contributes to p53 accumulation and 
activation (Chen et al., 2005; Stad et al., 2001).
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The role in Cdc25A degradation after DNA damage, which is important not only in 
Gl/S but also in S phase checkpoints, was instead questioned by recent reports about new 
and more effective Chkl dependent phosphorylation sites in Cdc25A, that could lead to 
protein degradation through the interaction with the pTrCP protein (Jin et al., 2003).
Chk2 role in G2/M checkpoint seems exerted through the phosphorylation of Ser216 
in Cdc25C (Figure 8 ), a site known to be involved in negative regulation of this protein 
(Peng et al., 1997). The importance of this event is made unclear by the fact that the same 
site is a target of Chkl and p38 kinases, which could be however induced principally by 
UV treatments, more than IR, and by the unclear role for Cdc25C in G2/M arrest (Chen et 
al., 2001). It’s important to note that the description of every biological activity for Chk2 
in human cells is complicated by the partial overlap activity of the structurally distinct 
Chkl kinase. The functions of Chkl protein cooperate, overlap or alternate with those of 
the Chk2, depending on the organism and on the nature of the genotoxic insult.
Although many papers have been published underlining the importance of Chk2 in 
checkpoint arrest after DNA damage in human cells, by the production of Chk2"/‘ mice and 
mouse cell lines contrasting data were obtained. One paper (Hirao et al., 2000) shows in 
Chk2"/" murine cell lines the presence of defects in Gl/S checkpoint and in G2/M block 
sustainment, but not in S phase, while another one (Takai et al., 2002) shows defects only 
in Gl/S checkpoint sustainment, both concordant only for defects in p5 3 -dependent 
transcriptional activity. These data, in addition to the massive defects in cell cycle 
progression and checkpoint detectable in Chkl’7’ mice (Takai et al., 2000), suggest the 
hypothesis that Chkl has a main role in checkpoint, but also in unperturbed cell cycles, 
whereas Chk2 shows a complementary role in regulating cell cycle progression after 
certain types of DNA damage, particularly DSBs. However this model is derived basically 
from data obtained in mouse and it’s until now not demonstrated in humans and was not 
confirmed by data obtained from other organisms (see for example Drosophila mutants).
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Chk2 has been also involved in DSBs repair, a role carried out through the functional 
interaction of Chk2 with Brcal (Figure 8 ). BRCA1 protein is phosphorylated by Chk2 on 
serine 988 after IR treatments, and mutation of this residue prevents the dispersion of 
BRCA1 from sub-nuclear foci, that is imposed by DNA damage (Lee et al., 2000). 
Furthermore the same phosphorylation event seems essential to induce the homologous 
recombination promoting activity of Brcal (Zhang et al., 2004). This functional interaction 
could also in part explain the data obtained from epidemiological evidence, which 
implicated Chk2 and BRCA1 in the same breast cancer prevention pathway (Sullivan et al., 
2002). It’s not possible to exclude that Chk2-Brcal relation could also be involved in cell 
cycle arrest, since Brcal has been already implicated in this field.
Chk2 involvement in apoptotic activation is suggested by many observations: the 
only clear defect detectable in Chk2'/' mice and mouse embryo fibroblasts (MEFs) is that 
they fail to undergo DNA damage-induced apoptosis (Hirao et al., 2000), the S516A 
mutant (a Chk2 autophosphorylation site) is defective in ionizing radiation-induced 
apoptosis and Drosophila homolog shows a role in DNA damage induced apoptotic events 
(Peters et al., 2002). The relevance of p53 in this Chk2 activity (Figure 8 ) is controversial 
and only recently was proposed an effect of Chk2 not in inducing p53 accumulation but in 
activating the latent population of p53 preexistent to the post IR accumulation (Jack et al., 
2004). However other studies also propose a role of Chk2 in apoptosis through a p53- 
independent pathway, until now not elucidated. A possible pathway could act through E2F- 
1 protein, a Chk2 phosphorylation target (Figure 8 ); E2F-1 could prompt apoptosis through 
different pathways, p53-dependent or independent, inducing transcription of pl4/Arf, p73 
and Apafl (Pediconi et al., 2003; Hallstrom and Nevins, 2003). An alternative mechanism 
is the Chk2 dependent phosphorylation of the proapoptotic protein PML (Yang et al., 
2002; Bemardi and Pandolfi, 2003).
Chk2 was also found interacting with two members of the Polo like kinases, Plkl and 
Plk3 with roles until now not elucidated (Tsvetkov et al., 2005; Xie et al., 2002; Figure 8 ).
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Emerging evidences suggest a role for Chk2 and other members of the DNA damage 
pathways in senescence response to telomere shortening (D’Adda di Fagagna et al., 2003; 
Gire et al., 2004), but also in premature senescence after uncontrolled replication, due to 
activation of oncogene Ras (d’Adda di Fagagna, personal communication). In this case 
senescence could be considered as an irreversible arrest of cell cycle progression, due to 
activation of checkpoint pathways also in absence of a direct damage. These observations 
could also be linked to recent data, demonstrating that in precancerous lesion, in presence 
of oncogene expression and consequently uncontrolled replication, the DNA damage 
response is constitutively activated, and particularly Chk2 is phosphorylated in the 
regulatory site threonine 6 8  (Bartkova et al., 2005; Chen et al, 2005).
The role of Chk2 as tumor suppressor, suggested for the involvement in the global 
checkpoint response was emphasized by the identification of germline and somatic 
mutations of the CHK2 gene in human hereditary and sporadic tumours, respectively. 
Mutations of CHK2 have been found associated with the Li-Fraumeni-like multicancer 
syndrome (Bell et al., 1999; Vahteristo et al., 2001), with familial breast cancer 
(McPherson et al., 2004) and with sporadic tumours as myelodysplastic syndromes, 
osteosarcomas, vulval neoplasia, breast cancer, lymphoid malignancies and rarely in lung, 
ovarian tumors and urinary bladder (for a review see Bartek and Lukas, 2003).
5. IONIZING RADIATION AS A MODEL TO STUDY THE DNA DAMAGE 
RESPONSE
The reason for the use of IR as a model to elucidate mechanism of DNA damage 
response is that cells have very specific mechanisms for the detection of radiation injury 
and for dealing with its consequences, either by repairing the damage, or by committing 
suicide. One of the reasons why cells possess these specific mechanisms is that organisms 
have evolved and adapted to the presence of radiation, in the form of sunlight (ultraviolet
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light), from radioactive elements in the earth, and from space. Nuclear DNA damage is the 
critical firing of IR-induced cell response, in fact although there are cellular mechanisms 
suggesting that the cell membrane is a target of death in some instances (Haimovitz 
Friedman et al., 1997), early experiments demonstrated that damage to the DNA is more 
than 3000 times more effective than membrane damage in the killing of cells in vitro 
(Warters and Hofer, 1977).
6. BASIC SIGNAL TRANSDUCTION CASCADE IN CHECKPOINT 
ACTIVATION
Cell cycle checkpoints are regulatory pathways that govern the order and the timing 
of cell cycle transitions, to ensure the correct completion of one cellular event before to the 
starting of another one.
6.1 The Gl/S checkpoint
In presence of the correct conditions, during G1 phase of the cell cycle, cells could 
take the decision to replicate DNA and divide (for a review see Harper and Brooks, 2005). 
This decision is taken at the so-called ‘restriction point’ in mid-to-late G1 and seems 
irreversible until the next G1 phase. The main events that trigger S phase initiation are 
Cdk2 accumulation and activation (Bartek and Lukas, 2001). During G1 the presences of 
Rb-E2F complexes suppress transcription of genes required for DNA synthesis and 
particularly Cdk2 (Figure 9). Growth factors lead to increase in cyclin D, Cdk4/6 and E2F 
levels, Cdk4/6 phosphorylated Rb leading to E2F release, E2F induce transcription of 
cyclin E, Cdk2, E2F and others S phase regulators (Figure 6 ). Finally Cdk2 is activated not 
only by cyclin E interaction, but also by Cdc25A phosphatase dephosphorylation of 
inhibitory sites (Figure 9).
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When a DNA damage is occurred in G1 phase, a cell cycle arrest is imposed through 
a pathway that requires transcription, translation and/or protein stabilization of key 
checkpoint transducers and, central to this pathway, is the accumulation and activation of 
the p53 protein (for a review see Fei and El-Deiry, 2003), while the final effect is the 
inhibition of Cdk2 activity and accumulation. Under normal conditions, p53 is a highly 
unstable protein and its DNA binding capacity is low. Furthermore, in normally growing 
cells, p53 levels are kept low due to interaction with Mdm2, which targets p53 for nuclear 
export and proteasome-mediated degradation in the cytoplasm (Figure 3). Furthermore 
MdmX interacts directly with p53 and inhibits its transactivation activity (Marine and 
Jochemsen, 2004). Following IR damage, ATM activates downstream kinases, which in 
turn phosphorylates residue serine 20 (Ser20) of p53. The Ser20 phosphorylation of p53 
blocks p53/Mdm2 interaction, resulting in p53 escape from degradation and consequently 
accumulation (Figure 3). The Ser20 phosphorylation has been attributed for a large time to 
the ATM downstream kinase Chk2, but this assumption was questioned by different 
authors (Ahn et al., 2003; Jallepalli et al., 2003). ATM is capable to control p53 stability 
also by directly phosphorylating the p53 negative regulator, Mdm2, on Ser395 (Maya et 
al., 2001). This modification allows Mdm2/p53 interaction, but prevents p53 nuclear 
export from the cytoplasm at site of degradation. A direct ATM and ATR phosphorylation 
site in p53 protein is Seri 5, an event that seems crucial in enhancing p53 transcriptional 
transactivation activity, probably increasing its DNA binding capacity. Seri 5 is rapidly 
targeted by ATM after IR and only with a slow kinetics by ATR, while in response to UV 
or replication block only ATR seems involved. ATM and Chk2 act in synergy not only on 
p53, but also in MdmX phosphorylation, another level for p53 activation regulation. 
Following DSBs, MdmX is phosphorylated by ATM and Chk2, leading to nuclear 
retention and subsequent degradation of this protein (LeBron et al., 2006). MdmX is an 
inhibitor of p53 transactivation, therefore this destabilization could contribute to p53 
activation after DNA damage. Numerous other post-translational modifications, such as
sumoylation, acetylation, seems necessary to lead to a complete stabilization of the p53 
protein and activation of its sequence-specific DNA binding. Activated p53 up-regulates a 
number of target genes, several of which are involved in the DNA damage response and, 
among them, there are effectors for cell cycle arrest (Mdm2, GADD45a, Reprimo, and 
p2 1 wafi, pjgure 3 ) Particularly the accumulation of p21wafl, a protein that forms inhibitory 
complexes with a class of cdk-cyclins, leads to the suppression of Cyclin E/Cdk2 kinase 
activity, thereby resulting in G1 arrest (Figure 9).
However in mammalian cells if the damage occurs in late G l, when S phase has been 
already programmed, the Gl/S checkpoint shows a two-wave model of arrest. An initial, 
rapid, transient and p53-independent response is activated before the delayed, but more 
sustained, arrest imposed by the p53-p21wafl pathway (Figure 9). The block of progression 
within minutes after DNA damage should be obtained through a mechanism independent 
of transcription and protein synthesis, two processes that require time consuming. For G l- 
S a way for a rapid activation of cell cycle arrest is the induction of Cdc25A degradation 
(Figure 9). The abundance and activity of Cdc25A rapidly decreases, when mammalian 
cells are exposed to DNA damaging agents, in consequence of poli-ubiquitination and 
subsequent degradation of the Cdc25A protein by proteasome (for a review see Bartek and 
Lukas, 2001). This degradation results in persistent inhibitory phosphorylation of CDK2 
on tyrosine 15, and consequent inhibition of cyclin E-CDK2 activity with the final result 
to block Gl/S transition. The signal for Cdc25A ubiquitination after damages is obtained 
through the activation of different pathways and is started by phosphorylation of Cdc25A 
in several residues. One of these aminoacids is serine 123, a target of the ATR/Chkl and 
ATM/Chk2 pathway (Figure 9).
Therefore despite the fact that the initial steps are common for the Cdc25A and p53 
pathways, their impact on Gl/S progression are separated in time, due to the dependence of 
the latter pathway on transcription and protein synthesis.
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6.2 The S phase checkpoint
DNA-modifying agents cause lesions that must be repaired before the DNA is 
copied, in order to prevent the replication machinery pairing an incorrect base with the 
modified one. Other agents, such as hydroxyurea, have the potential to damage 
chromosomes by interfering directly with the progress of replication forks, leading to 
incomplete replication and subsequent chromosome breakage. Cells respond to such events 
encountered during chromosome replication, by slowing the rate of DNA synthesis with 
existing replication forks being stabilized, whilst unfired late replication origins are 
prevented from initiating new replication forks. The role of S phase checkpoint is 
particularly important, because although the G2 checkpoint should block any cells that 
have exited S phase with damaged DNA, during S phase cells have the opportunity to 
perform error-free repair via homologous recombination, due to the presence of sister 
chromatids. Differing from other checkpoint pathway that cause a cell cycle arrest, the 
intra-S checkpoint could only slow down the progression in the cycle, although this can 
persist for several hours.
In budding yeast this checkpoint is largely studied and recently many aspects of this 
process have been elucidated. Specific role in S phase delay, fork stabilization and 
recombinational DNA repair have been attributed to Mecl (ATM homolog), Rad53 (Chk2 
homolog) and other proteins (Longhese et al., 2003). On the contrary this pathway is the 
least understood of the mammalian checkpoints. Cells derived from individuals affected 
with ataxia telangiectasia (AT) or Nijmegen breakage syndrome (NBS) fail to slow their 
rate of DNA replication following IR exposure: a phenomenon named radio-resistant DNA 
synthesis (RDS). These findings implicate the associated gene products (ATM and NBS1, 
respectively) in the S-phase checkpoint pathway. Furthermore different proteins are 
activated during the S phase according to the damage inferred: IR could induce DNA 
breaks that induce multiple ATM-dependent cascades that slows DNA synthesis and
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blocks new replication origin firing, while UV lesions fork arrest and replication errors 
could induce ATR/Chkl and ATR/Brcal responses leading to origin firing delay.
ATM has a leading role in almost two different signaling pathways, in response to IR 
damages during S phase progression. The first involve ATM/Chk2/Cdk2 pathway, the 
same that is functional in G1 (Figure 9). This according to the fact that Cyclin AJ or Cyclin 
E/Cdk2 complexes are essential to start (particularly Cyclin E/Cdk2), but also to progress 
(particularly Cyclin A/Cdk2) in DNA replication (Jackman et al., 2002) (Figure 9). 
Therefore Cd25A degradation could also induce an intra-S checkpoint pathway to have an 
effect on Cdk2 activity, particularly blocking CyclinA/Cdk2 role in Cdc45 recruitment, 
during replication complex loading on origin and the resulting blockade of de novo 
initiation of late origins (Figure 9). However it is important to underline that the 
importance of Chk2 phosphorylation in Cdc25A Seri 23 has been partly revised, because 
other kinases, phosphorylation sites and interactors have been discovered (Busino et al., 
2003; Jin et al., 2003). As for other checkpoints, the ATM/Chk2 pathway seems central in 
response to IR, while ATR/Chkl pathway has a major role after UV or HU treatments.
The second branch of the IR-induced S-phase checkpoint pathway is dependent, 
other than ATM, also on Nbsl protein (Yazdi et al., 2002). Upon IR damage, ATM 
phosphorylates a number of downstream substrates including NBS1 (at multiple sites 
including Ser343), BRCA1 (at multiple sites including Serl387) and SMC1 (at Ser957 and 
Ser966), while Mdcl protein recruits Mrell/Rad50/Nbsl complex at site of DNA damage. 
Loss of any of these proteins (ATM, Nbsl, Brcal, Mdcl), or mutation in the indicated 
phosphorylation sites, results in defects of S-phase checkpoint activation. How this 
checkpoint is activated through this pathway and the relations between the involved 
proteins are until now unknown. A possible suggestion could arise from the fact that NBS1 
and BRCA1 proteins are required for optimal phosphorylation of SMC1 upon IR and the 
ATM, NBS1, and BRCA1 proteins have all been shown to be part of a mega-dalton sized
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protein complex named BASC (BRCA1 -associated genome surveillance complex), that 
also include numerous other DNA repair and replication factors (Wang et al., 2000).
6.3 The G2/M checkpoint
The G2 cell cycle checkpoint allows suspension of the cell cycle prior to 
chromosome segregation, a critical step in cell duplication (for a review see O’Connell et 
al., 2000). Also in this case, as for Gl/S checkpoint, in presence of a DNA damage an 
arrest could be induced through the induction of phosphatases activity on inhibitory site of 
cyclin dependent kinases. In G2/M the phosphatase is Cdc25C and the kinase is Cdc2 
(Figure 10). Maintenance of the inhibitory phosphorylations on Cdc2 (on Thrl4 and 
Tyrl5) is one of the mechanisms for G2 checkpoint activation (Figure 10). Upon DNA 
damage, Chkl and Chk2 kinases, activated by ATR- and ATM, respectively, 
phosphorylate Cdc25C on position Ser216 (Chaturvedi et al., 1999). This phosphorylation 
creates a binding site for the 14-3-3 proteins that sequester Cdc25C in the cytoplasm, 
thereby preventing that this phosphatase activates Cdc2 through removal of the inhibitory 
phosphorylations (Dalai et al., 1999, Figure 10). This results in the maintenance of the 
Cdc2/Cyclin B1 complex in its inactive state and blockage of entry into mitosis. A major 
role in this pathway is played by ATR and Chkl also in response to IR other than, as usual, 
after treatments with UV. However, about the importance of this pathway contrasting data 
have been obtained (Lopez-Girona et a l , 2001).
Another possible target of ATM after DNA damage is Plkl (van Vugt et al., 2001), a 
kinase protein that shows activity on Cdc25C. Plkl role in G2/M checkpoint was 
underlined by the inhibition of its activity after damage and by the partial abrogation of G2 
arrest in cells with Plkl mutants in the inhibitory sites. Plkl was also found interacting 
with Chk2 (Tsvetkov et al., 2005), underlining the role of both proteins in G2/M 
checkpoint.
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P53 and p21wafl seems also to participate to G2/M checkpoint (Figure 10), 
particularly in some cell types. P53 has been described as a repressor of Cdc2 and cyclin B 
transcription and as a transcriptional inducer of Gadd45, a Cdc2 inhibitor acting as 
competitor of cyclin DI (Taylor and Stark, 2001). P21wafl protein acts instead on G2/M 
progression, sustaining the block through a mechanism until now unclear, that seems to 
involve Cdc2 activation (Smits et al., 2000).
Finally, in presence of an UV damage a G2 delay is also obtained through p38, a 
cytoplasmic kinase that, phosphorylating Cdc25B, abrogates the nuclear import of this 
phosphatase that acts on Cdc2 (Mikhailov et a l , 2005).
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FIGURE 1: Schematic representation of the more relevant DNA damage sources,
lesions and repairing systems.
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Damage Events per hour
Depurination 580
Depyrimidation 29
Deamination of Cytosine 8
Single-Stranded Breaks 2300
Single-Stranded breaks after depurination 580
Methylation of Guanine 130
Pyrimidine (thymine) dimmers in skin (noon day sun) 5 x  104
Single-stranded Breaks from Background Radiation l x l O-4
Double-stranded Breaks from Background Radiation 4 x 10'6
TABLE 1: DNA damaging events per hour per cell.
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FIGURE 2: The global DNA damage response.
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Damage Repairs per hour
Single-stranded breaks 2 x 105
Pyrimidine dimers 5 x  104
Guanine methylation 104-105
TABLE 2: Maximum DNA repair Rates in a Human Cell.
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FIGURE 3: p53 activities in response to DNA damage. In absence of DNA damage 
(upper left) p53 protein is bound by Mdm2 or MdmX and conducted to degradation 
through the ubiquitination-proteasome pathway. When DNA damages occur p53, Mdm2 
and MdmX proteins are modified principally by phosphorylation events, these leading to 
p53 accumulation (upper right) and transcriptional activity enhancement (lower). Some 
p53 targets and their role in DNA damage response are resumed.
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Disease Frequency
Neurological
Features Immunodef.
Chr.
Instability Cancer risk Radiosens.
Other Protein
Ataxia
Telangiectasia
1/70000 
live births
Cerebellar
degeneration
cellular and 
humoral
+
lOOx cancer risk 
70x leukemia 
500x lymphoma
+
telangiectasia,
frequent
infections
ATM
Nijmegen
Breakage
Syndrome
-130  cases
Microcephaly
Growth
retardation
cellular and 
humoral
+ 5 Ox cancer risk 
100 Ox lymphoma
+ frequent
infections
N bsl
Ataxia 
Telangiectasia 
Like Disease
6 cases
Cerebellar
degeneration -
+ - +
no
telangiectasia
M rell
TABLE 3: Principal clinical and cellular features in Ataxia Telangiectasia, Nijmegen 
Breakage Syndrome and Ataxia Telangiectasia like Disease.
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FIGURE 4: Schematic representation of ATM, Nbsl and Chk2 proteins with known 
domains and phosphorylation sites. ATM is a large protein characterized by a C-terminal 
Kinase Domain and by a relevant autophosphorylation residue (SI981). In Nbsl protein 
two highly conserved domains were described: a BRCT and an FHA domain are present in 
the N-terminus region. An Mrel 1 binding domain (M) is located at C-terminus, S3 63 is an 
ATM dependent phosphorylated residue. Mrel 1 is characterized by a phosphoesterase 
domain and two DNA binding domains (DBD) which are essential for its role in broken 
DNA ends tethering. Chk2 is a kinase protein with a highly conserved kinase domain, a 
Serine/Threonine rich domain in the N-terminus containing a large number of SQ and TQ 
sites which are preferentially substrate for ATM activity (T68 is the principal). A FHA 
domain is also present to bind phosphorylated proteins and dimerize. Dimerization leads to 
autophosphorylation in T383 and T387, two regulatory residues, producing a fully active
kinase (see also Figure 7).
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FIGURE 5: ATM activation and downstream activities. In presence of also a low 
number of double strand breaks and probably as a consequence of a chromatin 
rearrangement, ATM proteins, which normally is in a dimerized inactive state, after an 
autophosphorylation event in S1981 monomerize and change conformation becoming 
active. ATM kinase phosphorylated many downstream substrates, some of them are 
resumed in the left lower part of the figure. ATM is able to modify and induce the 
formation of protein agglomerates, named foci, that span many megabases around the 
lesion, and seems implicated in lesion protection, processing and repair and in checkpoint
signal transduction.
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FIGURE 6 : Schematic representation of M re ll, Rad50, Nbsl complex formation and 
activity. Nbsl (N) protein is essential to translocate the Mrel 1 (M) and Rad50 (R) 
complex. In absence of Nbsl the same complex is unstable and located in cytoplasm. In 
presence of a damage ATM phosphorylates Nbsl in Ser343 leading to the formation of 
large agglomerates of many molecules of M/R/N complex around the damage (foci). 
M/R/N can tether DNA extremities in close proximity and with exo and endonuclease 
activity can process the lesion, enhancing recombination and stimulating DNA repair. The 
same complex shows a role in checkpoint regulation.
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FIGURE 7: Schematic description of Chk2 activation events. When a DNA damage 
occurs ATM is activated and phosphorylates Chk2 in the TQ/SQ domain (S/T), leading to 
a partial induction of its kinase activity. The phosphorylated monomeric form of Chk2 
dimerize through the interaction between S/T region and the FHA domain of another Chk2 
molecule that could be either phosphorylated or not. Dimerization leads to in trans 
autophosphorylation and dimers breakage, with the final result of two active molecules.
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FIGURE 8: Chk2 substrates and interactors. In the upper part of the figure Chk2 
substrates are summarized with the target residue and the role of these modifications in the 
global DNA damage response. In the lower part physical interactors are visualized, with 
specified, when known, the compartment, the condition or the role of the interaction.
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FIGURE 9: ATM and Chk2 dependent G l-S and intra S phase checkpoints. In
presence of a DNA damage ATM and Chk2 are sequentially activated and could 
phosphorylate downstream substrates (red arrows). P53 is phosphorylated by ATM in 
Seri 5 and by Chk2 in Ser20, both events leading to p53 accumulation and activation. 
P2 i wafl *s transcriptional induced by p53 and is able to block Cdk2-CyclinE complex 
leading to an arrest of Gl-S progression. Chk2 also phosphorylates Cdc25A phosphatase in 
SI23 prompting Cdc25A to degradation. Cdc25A absence leads to a cell cycle arrest 
because this phosphatase in a normal cell cycle is essential for the dephosphorylation and 
activation of Cdk2-cyclin E complex in G1 cells, or Cdk2-cyclin A complex in early S
cells.
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FIGURE 10: ATM and Chk2 dependent G2-M checkpoint. In presence of a DNA 
damage Chk2 is activated by ATM and, in coordination with ATM itself, phosphorylates 
p53 leading to accumulation and activation of this target. P53 transcriptionally induces 
many substrates, among them p21watl that blocking Cdc2-cyclin B complex arrests G2-M 
progression. Chk2 reinforces G2-M checkpoint modifying Cdc25C and excluding this 
phosphatase from the nucleus, leading to accumulation of phosphorylated and inactive
Cdc2-cyclin B complex.
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AIM OF THE WORK
The main aim of this thesis was to elucidate of the mechanisms of Chk2 protein kinase 
activation in response to DNA damage, starting from earlier evidences showing that this 
kinase is activated by phosphorylation in an ATM-dependent manner in cells treated with 
ionizing radiation (IR).
In the first part of my thesis I investigated the role of Nbsl, a protein deficient in Nijmegen 
Breakage Syndrome (NBS), which shares with Ataxia Telangiectasia (AT) common 
clinical features including radiosensitivity. For this purpose I compared the 
phosphorylation and catalytic activity of Chk2 in cells derived from patients with AT and 
NBS with normal cell lines. Furthermore, using specific Nbsl mutants I studied the role of 
the Nbsl/Mrel 1/Rad50 complex in this response.
In the second part of my thesis, because of the pivotal role of ATM and NBS1 in the 
cellular response to radiation, I evaluated the kinetics of Chk2 activation in normal, AT 
and NBS cell lines treated with IR, UV light and hydroxyurea.
DNA single and double strand breaks are the main lesions produced by IR as well as by 
oxidative stress. Having found that Chk2 is preferentially activated by IR, I analyzed the 
dependence of this event on ATM and Nbsl proteins, and investigated Chk2 activation in 
relation to the amount of single and double strand breaks induced by IR and hydrogen 
peroxide. The yield of DNA breaks for each treatment dose was estimated by the 
neutral/alkaline elution and by y-H2AX immunostaining. The activation of ATM and Chk2 
kinases were evaluated using different in vitro and in vivo approaches to overcome limits 
in sensitivity by each assay. In this way I investigated the presence of lesion specificity for 
the ATM and Chk2 response, the importance of the source of damage when the lesions 
produced were comparable, and the possible presence of a threshold amount of DNA 
lesions necessary for a complete and sustained activation of each kinase.
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MATERIALS AND METHODS
1. CELL LINES AND CULTURE PROCEDURES
1.1 Cell lines
Lymphoblastoid cell lines (LCLs) were derived from human lymphoblasts 
immortalized by Epstein-Barr virus (EBV) infection. LCL-N, LCL-N1 and LCL-N2 were 
obtained from normal individuals, AT52RM from an Ataxia Telangiectasia (AT) patient, 
524RM and 227RM from two AT-heterozygotes, 1548 from an Italian Nijmegen Breakage 
Syndrome (NBS) patient. GM07078 (NBS patient), GM08036 and GM08037 (NBS 
heterozygous parents) were obtained from the Coriell Cell Repository (Camden, N.J.).
FB-N and 18ATRM are established fibroblasts from a normal individual and an AT 
patient, respectively. GM07166 are established fibroblasts derived from the same NBS 
patient as GM07078) and were obtained from the Coriell Cell Repository (Camden, N.J.).
ILB1 are SV40-immortalized NBS fibroblast, GM07166/NBS1 are fibroblasts stably 
transfected with the full length NBS1 cDNA, GM07166/s590 are stably transfected cells 
with the NBS1 truncated cDNA at codon 590, and ILB1/S343A are stably transfected with 
NBS1 with a serine to alanine substitution at aa343. Immortalized fibroblasts were 
obtained from Dr. Komatsu and Dr. Khanna laboratory.
MCF-7 cells are derived from a human breast adenocarcinoma tissue, while HCT116 
and HCT116 Chk2'/_ are wild type and Chk2 null colon cancer cells and were obtained 
from Drs. B. Vogelstein and F. Bunz (Johns Hopkins Cancer Center, Baltimore, MD).
1.2 Maintenance of cell lines
Cells were maintained at 37° C and 5% CO2 in a Heraeus humidified incubator and 
all procedures were carried out in a Laminar flow hood.
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The LCL cell lines were cultured in suspension in flasks using with RPMI 1640 
medium supplemented with 15% heat inactivated fetal calf serum (FCS), penicillin 
(lOOU/ml) and streptomycin (lOOjuig/ml). The medium was changed twice a week, unless 
otherwise indicated in specific experiments.
Fibroblasts and MCF-7 were maintained in adhesion in Petri dishes with DMEM 
medium supplemented with the same serum and antibiotics concentrations as for 
lymphoblastoid cells. HCT116 wild type and knock out cells were cultured in McCoy's 5A 
medium with 10% fetal bovine serum and antibiotics as above. Transfected GM07166 
were maintained in medium supplemented with 100 pg/ml hygromicin, while transfected 
ILB1 were cultured with 500 pg/ml geneticin.
Cells were routinely passaged when they became confluent (every 2-3 days). The cell 
monolayer was washed with phosphate buffered saline (PBS) to remove serum (which 
inactivates trypsin) and then 2-6ml of 0.1% Difco Trypsin/EDTA (AnalaR BDH) was 
added to each flask and incubated for 5 minutes at 37° C. When cells had detached from 
the flask, trypsin was inactivated by adding 5ml of standard growth medium, and the cell 
suspension was pelleted by centrifugation at 1500 rpm for 8 minutes. The cells were then 
resuspended in standard growth medium and re-plated at an appropriate split ratio (1:3-1:5) 
for the cell line.
All cell lines used were routinely tested and found to be free of mycoplasma 
contamination.
1.3 Storage and retrieval of cells in liquid nitrogen
Frozen cell stocks in liquid nitrogen were routinely prepared. Lymphoblastoid cells 
were directly collected while fibroblast were trypsinized and in both cases resuspended in 
standard growth medium containing 10% dimethylsulphoxide (DMSO). 1ml aliquots were
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frozen in cryotubes (L.T.I.) in a -80°C freezer for at least 24hrs, and then stored submerged 
in liquid nitrogen.
Cells were recovered from liquid nitrogen by thawing rapidly in a 37°C water bath 
and washing with 10ml of standard growth medium to remove the DMSO. Cells were 
centrifuged at 1500rpm for 8 minutes, resuspended in fresh medium and plated.
2. IRRADIATION AND TREATMENTS
2.1 Irradiation of cell cultures
1 0*7
Cells were y-irradiated using a Cs source emitting a dose rate of 8 Gy/min. 
Routinely cells were irradiate at room temperature, for the evaluation of the DNA strand 
breaks produced by ionizing radiation exposure the cells were irradiate on ice.
2.2 Hydrogen peroxide treatments
The cells were deprived of the culture medium (conditionated medium) by 
centrifugation and the conditionated medium was stored at 37°C. Cells were exposed for 
lhr to the indicated hydrogen peroxide concentration (Sigma, Italy) in PBS solution at 
37°C. After this period each sample was washed twice with PBS and resuspended in its 
own conditionated medium.
2.2 4-nitroquinoline 1-oxide (4-NOOf and Hydroxyurea (HU) treatments
4-NQO UV mimetic drug (Sigma, Italy) in a stock solution of 2mM in ethanol was 
added to the cells washed from medium and resuspended in PBS, for lhr at the indicated 
concentration. After this period cells were washed twice with PBS and resuspended in 
fresh 37°C culture medium, lhr later total lysates were prepared or cells were cytospun on 
glass slide for immunofluorescence staining.
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HU (Sigma) was dissolved in PBS at a concentration of 500mM and added to cells at 
the indicated concentration for 24 or 48hrs. After this period cells were washed twice with 
PBS and total lysates were obtained. A part of the sample was prepared for cytometric 
analysis as described above.
3. PROTEIN ANALYSIS BY SDS-PAGE
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was used 
to determine changes in the expression or migration of proteins. This technique is a method 
by which proteins can be separated based on their molecular weight by the relative distance 
they migrate through a polyacrylamide gel matrix.
3.1 Sample preparation
Cells were collected and washed twice with PBS buffer supplemented with 0.1 mM 
Na3V0 4  (Sigma), a phosphatase inhibitor. Cells were pelleted at 5000 rpm 10 minutes and 
lysed in 10pl/lxl06 cells of Laemmli buffer (0.125M Tris-HCl, pH 6.8, 5%SDS). Lysates 
were boiled at 95°C for 5min, placed on ice and when at room temperature an equal 
volume of Laemmli buffer containing as inhibitors ImM PMSF, lpg/ml pepstatin, 
lOOKIU/ml aprotinin, lOpg/ml leupeptin (all from Calbiochem)lmM EDTA, lOmM NaF 
and ImM NasVCU was added. The suspensions were sonicated for 30sec. to dissolve DNA 
and quantified by the micro-BCA method (Pierce, Rockford, IL). Samples were stored at - 
80°C.
3.2 Preparation of acrvlamide gels
The gel apparatus used in these experiments was a Hoefer Mighty Small II. A 7.5cm 
running gel (see Table) with a 2cm stack was prepared, using a 0.75mm spacers and well
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former. To prepare the gel, a mix of separating buffer IX (see table), APS, Temed and 
polyacrylamide/bis-acrylamide 29:1 at the necessary concentration was prepared and pour 
between two glass slides separated by two 0,75 mm flat spacer so that the level is 2 cm 
below the comb. A 10% running gel was used for optimum resolution of the p53 protein, a 
8% was used for Chk2 and Nbsl, a 5% for ATM and a 12.5% for p21wafl. All proteins 
required a 4.5% stacking gel prepared with a stacking buffer (see Table) in addition to the 
running gel.
3.3 Samples loading
The prepared lysates were thawed and 40pg of total protein in 5-20pl of Laemmli 
buffer were used for each sample. 10X loading buffer (Tris HC1 0,25 M, SDS8%, glycerol 
30% and bromophenol blue 0,2% pH 6,8) was added to a final IX concentration. The 
samples were boiled at 95°C 5 minutes and microfuged briefly to pellet any debris before 
loading onto the gels. In addition, 7pi of prestained Rainbow molecular weight marker 
(14.3-220kDa; Amersham, UK) was also loaded in a lane. Gels were run for approximately 
5 hours in running buffer (see Table) initially at 50 V and then at 70-80V, until the dye 
front reached the end of the gel. For Chk2 band shift analysis a 12cm long gel was used 
and the run was extended up to 8 hours to a better separation of the phosphorylated forms 
of the protein.
3.4 Western transfer and immunoblot
Proteins were transferred onto a polyvinylidine difluoride (PDVF) membrane 
(Immobilon; Millipore), a microporous membrane with high protein binding capacity.
After discarding the stacking gel, the running gel was soaked in ice-cold transfer 
buffer for 10 minutes to remove the SDS. The Immobilon membrane is extremely 
hydrophobic and was therefore pre-soaked in 100% methanol for 5 minutes, and then
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rinsed thoroughly in distilled water to remove the methanol. Finally membranes were 
equilibrated in transfer buffer for 10 minutes.
The proteins were transferred from the gel to the Immobilon membrane by a Semidry 
Electroblotting (BioRad) at 90mA for lhour. Equilibrated PVDF membrane was put over 
two pieces of 3MM paper wet with transfer buffer. The gel was put over the PYDF 
membrane and overload with other two pieces of wet 3MM paper. Usually transfer was 
performed at 100-120mA for lhour.
The resulting membrane was first washed 2 times with 50mM Tris-HCl pH 7.5, then 
equilibrated in PBS+0.1% Tween20 and finally blocked for 20 minutes in milk blocking 
buffer (see Table) at RT. The primary antibody was added to the membrane in 10ml of 
milk blocking buffer and the incubation was performed over night at room temperature. 
After incubation unbound primary antibody was removed with three washes of 10 minute 
in PBS+0.1% Tween20. The only exception was done for the phosphospecific antibody 
T68P that was diluted in PBS+3% BSA in presence of 0.1% Tween20, this to avoid the 
interference of serum phosphoprotein in epitope recognition.
Incubation with the secondary antibody was performed in a similar way as described 
for the primary antibody. In all cases, anti-mouse or anti-rabbit IgG horseradish peroxidase 
conjugate (Amersham), were used at a concentration of 1:2000. The membrane was 
incubated with the secondary antibody for 1 hour at room temperature and then washed 
three times for 10 minutes PBS+0.1% Tween20.
When a reprobe was necessary a treatment with 0.1% sodium azide, to eliminate the 
residual peroxidase signal and extensive washings in PBS+0.1%Tween20, were utilized.
3.5 The ECL detection system
Proteins were detected using the Enhanced Chemiluminescence (ECL) detection 
system. This is a rapid, highly sensitive, non radioactive method for the detection of 
immobilized proteins. In the ECL reaction, the substrate luminol is oxidised by a
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horseradish peroxidase catalysed reaction resulting in blue light emission. This can be 
detected using blue light sensitive film. The immunoreactive bands were visualized by 
ECL Super Signal (Pierce, Rockford, IL.) on autoradiographic films and quantified by 
optical densitometry using a DuoScan system (Agfa, Mortsel, Belgium) and ImageQuant 
software (Molecular Dynamics, Sunnyvale, CA.).
3.6 Antibody Concentrations
The membranes were incubated with specific antibodies for Chk2 (a rabbit antibody 
kindly provided by Dr. Nakanishi and used 1:200 and a mouse antibody, clone 44D4, 
produced with standard techniques), Chk2 phospho-Threonine 68 (1:200 kindly provided 
by Dr. Chen), Serine 19 (Cell Signaling, 1:800), Serine 33/35 (Cell Signalling, 1:1000), 
Nbsl (NB 100-143 polyclonal Novus Biologicals, Littleton, CO., 1:1000), p53 (DO-7, 
DAKO 1:1000), p53-P-Serl5 (clone 16G8, Signal Transduction, 1:200), p 2 r afl 
(Pharmingen BD, San Jose, CA., 1:100), actin (Sigma, Italy, 1:10000) and ATM (clone 
4D2 produced with standard techniques, 1:800).
3.7 SDS-PAGE western blot solutions
lOx loading buffer 
0.25M Tris-HCL pH 6.8 
8% (w/v) SDS (AnalaR)
36% (w/v) glycerol
20% (w/v) p-mercaptoethanol (Sigma)
0.2% bromophenol blue
lOx Running buffer 
1.9M glycine (AnalaR BDH)
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250mM Tris (AnalaR BDH)
1% (w/v) SDS
4x separating buffer 
1.5M Tris pH8.8 
SDS 0.4%
4x stacking buffer
0.5M Tris pH6.8 
SDS 0.4%
Transfer buffer 
1.9M glycine (AnalaR BDH) 
250mM Tris (AnalaR BDH)
20% (w/v) methanol (AnalaR BDH)
Blocking buffer 
lOmM Tris-HCL pH 7.4 
150mMNaCl
Tween 0.1% (w/v) (Sigma)
Milk 5% (w/v)
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4. GST RECOMBINANT PROTEINS PRODUCTION
The Cdc25C cDNA fragment encoding aa 200-256, kindly provided by Dr. 
Nakanishi, was cloned in the pGEX-4T-l vector, in frame with the GST tag and finally 
used to transform the E. coli strain BL21.
To induce protein production, an over night culture was diluted 1:10 in fresh medium 
supplemented with ampicillin, and grown to an O.D.6oo= 0.5. Next IPTG was added to a 
final O.lmM concentration and the growth continued for other three hours. Cells were then 
pelleted, washed with STE buffer (lOmM Tris-HCl pH8, 150mM NaCl, ImM EDTA) and 
resuspended in 4 ml of STE for each liter of culture. Lysozime was added to E. coli colture 
to a final concentration of 200pg/ml and left to digest on ice for 15 minutes, next 5 mM 
DTT, PMSF and 1.5% sarkosyl were added and samples frozen at -80°C. Bacterial cells 
were still lysed by repeated freeze-thawing cycles and sonication and the suspensions were 
clarified by centrifugation at 13000 rpm for 15 minutes. Sumatant was then applied to 
Glutathione-Sepharose 4B beads (Amersham-Pharmacia, 500 pi of slurry for each liter of 
bacterial culture) previously washed three times with PBS and once with PBS 1% Triton 
and incubated for 1 hour at 4°C with shaking. Beads were then washed 8 times with PBS 
and proteins were eluted over night at 4°C with 1 ml of 20mM Glutathione in PBS 0.1% 
Triton pH8. Purificated proteins were then quantified by SDS-PAGE and blue-coomassie 
staining (GEL-CODE, PIERCE).
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5. IMMUNOPRECIPITATIONS AND IN  VITRO KINASE ACTIVITY
5.1 Immunoprecipitations and phosphoresidues detection
For analysis of Chk2 phosphorylations in threonine 68 and threonine 387 residues 
two phosphospecific antibodies were used to evaluate the fraction of specifically modified 
in total Chk2 immunoprecipitated samples.
Lymphoblastoid cells were lysed on ice for 30 minutes in a lysis buffer containing 
150mM NaCl, ImM EDTA, 20mM Tris (pH 8), 0.5% Nonidet P-40 plus protease and 
phosphatase inhibitors (ImM PMSF, lpg/ml pepstatin, 2pg/ml leupeptin, 2pg/ml 
aprotinin, 25mM NaF, ImM Na3V0 4 ). Lysates, clarified by centrifugation (lOOOOrpm 10 
minutes), were quantified with Bradford assay (Biorad). The same amount of proteins for 
each sample (lmg of total lysate) was precleared with 10pi of Sepharose-Protein G 
(Sigma) for lhr and immunoprecipitated with 5pg of mouse 44D4/21 anti-Chk2 antibody 
and lOpl of Sepharose-Protein G at 4°C for 2hrs. After extensive washes the 
immunoprepitated molecules were solubilized in 20-30 pi in the same sample buffer used 
for SDS-PAGE, boiled for 10 minutes and centrifuged. Supernatants were analyzed by 
SDS-PAGE, and the phosphorylations on specific residues were revealed by pT68 and 
pT387 phosphospecific antibodies (Cell Signaling Tech., Beverley, MA) used, respectively 
1:800 and 1:300.
For the analysis of serine 1981 phosphorylation event on ATM protein, cells were 
lysed in a buffer containing 50mM Tris-HCl, pH 7.4, 1% Tween-20, 0.2% NP-40, 150mM 
NaCl, ImM EDTA plus protease and phosphatase inhibitors. Immunoprecipitations were 
performed with the same protocol as for Chk2 using the monoclonal anti-ATM antibody 
clone 4D2. Immunoprecipitated protein were run on a gel and immunoblotted with a 
phosphospecific antibody against S I981 (Rockland) at 1:200 dilution.
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5.2 ATM and Chk2 kinase assay 
To evaluate Chk2 kinase activity, cells were washed three times with PBS 
supplemented with ImM Na3VC>4 and lysed on ice for 30 minutes in a buffer containing 
50mM Tris-HCl, pH 7.4, 0.2% Triton X-100, 0.3% NP-40, 150mM NaCl, ImM EDTA 
plus protease and phosphatase inhibitors (ImM PMSF, lpg/ml pepstatin, 2pg/ml 
leupeptin, 2pg/ml aprotinin, 25mM NaF, ImM NasVCU). The clarified lysates were 
quantified with Bradford assay (Biorad). The same amount of proteins (l-2mg of total 
lysate) for each sample was precleared with lOjul of Sepharose-Protein G (Sigma) for lhr 
and immunoprecipitated with 5pg of mouse 44D4/21 anti-Chk2 antibody and lOpl of 
Sepharose-Protein G at 4°C for 2hrs. After extensive washes Chk2 kinase reactions were 
performed on immunoprecipitates at 3CPC for 30min in 20pl reaction mixtures containing 
50mM HEPES, pH 8.0, lOmM MgCl2, 2.5mM EDTA, ImM dithiothreitol, lOpM p- 
glycerophosphate, ImM NaF, O.lmM Na3V0 4 , O.lmM PMSF, 10pM ATP, 20pCi [y- 
32P]ATP and 1 pg of GST-Cdc25C fragment (aa 200-256) as a substrate. To stop the 
reaction samples were supplemented with 4pi of loading buffer and boiled 5’ at 96°C. The 
reaction products were separated on SDS-PAGE, and after autoradiography to evaluate [y- 
32P] incorporation, were Western blotted for Chk2 to verify the amount of 
immunoprecipitated protein per sample. To evaluate Chk2 autophosphorylation the GST- 
Cdc25C substrate was omitted in the kinase reaction.
ATM was immunoprecipitated from cells lysed in 50mM Tris-HCl, pH 7.4, 1% 
Tween-20, 0.2% NP-40, 150mM NaCl, ImM EDTA plus protease and phosphatase 
inhibitors, using the monoclonal anti-ATM antibody clone 4D2, and kinase reactions 
performed in a buffer containing 20mM HEPES, pH 8.0, 50mM NaCl, lOmM MgCl2, 
10mM MnCl2, ImM dithiothreitol, 20|rM ATP, 10|iCi [y-32P]ATP and ljug PHAS1 
substrate.
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6. NEUTRAL AND ALKALINE ELUTION ASSAY FOR DNA SSB AND DSB
Cells were labelled with 0.08 pCi/ml 2-14C thymidine for 24hrs at 37°C. After 
removal of the radiolabelled nucleoside precursor, cells were incubated for a further 24hrs 
prior to treatment with hydrogen peroxide or irradiation (the latter performed on ice). The 
neutral and alkaline elution procedures have been described elsewhere (Kohn et al., 1981). 
Briefly, after genotoxic treatments, the cells were layered on 2pm pore polycarbonate 
filters, lysed with a solution containing 2% SDS, 0.1M glycine, 25mM disodium EDTA 
(pH 10 for SSB, pH 9.6 for DSB) and 0.5mg/ml proteinase K, and the DNA eluted with a 
solution containing 0.1% SDS, 20mM EDTA (acid form) adjusted to pH 12.15 (for SSBs) 
or 9.6 (for DSBs) with tetrapropylammonium hydroxide. During the 15hrs of the elution 
procedure, fractions were collected and radioactivity measured by liquid scintillation. To 
allow a comparison between samples, the amount of DNA damage was converted into a 
fragmentation index (FI) based on the formula (1-r/ro, where r and ro are the fractions of 
[14C] DNA remaining on filters of treated and untreated cells, respectively), calculated 
after 12hrs of elution.
7. IMMUNOFLUORESCENCE TECHNIQUES
7.1 Detection of y-H2AX nuclear foci
Cells were cytocentrifuged (500 r.p.m., 7’) onto glass slides using a cytospin
instrument (Shandon), air dried over night. Fixation was performed for 20min at -20°C in
ice cold methanol, and thereafter in acetone (2’ at -20°C). After washing with PBS and
blocking for lhr with 3% BSA, the slides were incubated for 2hrs with 1:400 dilution of an
anti phospho-H2AX (Ser-139) antibody (clone JBW301, Upstate Biotechnology) and
thereafter with an F(ab)2  fragment of a FITC-conjugated secondary antibody for lhr. After
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3 washes in PBS, slides were counterstained with DAPI and mounted with an antifade 
solution (PBS + 75% glycerol + 0.2M DABCO). Images were collected using a Zeiss 
Axioskop fluorescence microscope and digital imaging. Nuclear foci were enumerated by 
two independent operators, on experiments performed three independent times and on 
duplicate slides.
7.2 Mrel 1 and total Nbsl immunostaining
The indirect immunofluorescence staining of cytospin preparations for Nbsl and 
M rell was performed as reported (Carney et al., 1998) using 1:50 to 1:100 dilutions of 
rabbit antibodies to NBS1 and MRE11 (both from Novus Biologicals). Nuclei were 
counterstained with DAPI.
7.3 Chk2 immunostaining
Immunofluorescence painting for Chk2 was performed on cytospins fixed for 10 min 
in 2% paraformaldehyde, washed in TBS, permeabilized with 0.1% Triton X I00 and 
incubated with 1:50 dilution of a rabbit anti-Chk2 antibody (Santa Cruz Biotech.). A 
normal rabbit serum was used as a negative control. Binding of primary antibodies was 
revealed with a FITC-labelled Fab2 goat anti rabbit antibody (1:50 dilution). Coverslips 
were mounted with the anti-fade solution supplemented with the DNA counterstain DAPI. 
The immunofluorescence specificity of Chk2 antibody was verified by competition with a 
recombinant full length Chk2 protein.
7.4 Detection of phospho-Thr68 Chk2 and phosphor-Ser343 nuclear foci
The immunofluorescence painting of the Chk2-Thr68 phosphorylated form was 
performed as described in Ward et al., 2001 and using a phosphospecific antibody kindly 
provided by Dr. Chen or using an antibody purchased from Cell Signaling Technology 
(Beverley, MA).
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The Nbsl-S343 phosphorylated foci were detected using the same technique 
described in Gatei et al., 2000 and a phosphospecific antibody kindly provided by Dr. 
Khanna.
8. RADIORESISTANT DNA SYNTHESIS ASSAY
The rate of DNA synthesis was measured by the 14C-/3H-thymidine double labeling 
method. Cells were prelabeled with 10 nCi/ml 14C-thymidine (Amersham Biosciences, 
UK) for 24 hours, then washed and incubated for 6 hours in non radioactive medium. 
Thereafter, cells were exposed to varying doses of y-rays and immediately seeded in a 96-
well plate in quadruplicates for a further incubation of 1 hour. Finally cells were pulse
 ^ •  •  • •labeled with H-thymidine at 2 pCi/ml for 15 minutes. Cells were washed with PBS,
trypsinized, trapped onto glass microfiber filters (Whatman GF/C), rinsed twice with an 
ice-cold 10% trichloroacetic acid, then with ice-cold ethanol and acetone, and air-dried. 
The radioactivity of each sample was quantified by a liquid scintillation counter (Packard 
TriCarb 2200CA) and the 3H/14C ratio (corrected for those c.p.m. that were the results of 
channel crossover), was taken as the rate of DNA synthesis. The ratio of incorporated H to 
14C was used for quantification to standardize the variation in DNA recovery. 
Quadruplicates were used to minimize the standard error of measurements.
9. FLOW CYTOMETRY PROCEDURES
Flow cytometry was used to determine the percentage of cells in the various phases 
of the cell cycle according to the DNA content.
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9.1 Propidium iodide (PI) staining for assessment of DNA content.
Single colour flow cytometric analysis of DNA content by PI staining was carried out 
essentially as described by O’Connor et al. (1993). Cells were trypsinized, washed in ice- 
cold PBS, and aliquoted at 1 x 106 cells per ml in PBS into FACS tubes (Falcon). The cells 
were pelleted by centrifugation at 3000rpm for 3 minutes, fixed in 1ml 70% ethanol and 
stored at -20° C for at least 24 hours. Cell pellets were vortexed before incubating in 1ml 
PBS with 150 pg/ml RNaseA (Sigma) and 20 pg/ml propidium iodide (Sigma) at 37° C for 
30 minutes. Stained cells were kept at 4° C in the dark overnight before analysis on a 
FACScan (Becton Dickinson). For all procedures, cells were excited with a single 488-nm 
argon laser and PI fluorescence was detected through a 585± 22nm filter. Red fluorescence 
data (FL3-Area and FL3-Width) were collected in list mode format to 10,000 total events 
using the LYSYS II program. Cell cycle analysis was carried out using the CellFIT 
program on FL3-A histograms (gated from cytograms of FL3-Area and FL3-Width, to 
exclude clumped cells), and the percentage of cells in G0/G1, S and G2/M were calculated 
using the rectangular fit (RFIT) model.
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RESULTS
1. NBSl DEPEDENCE OF CHK2 ACTIVATION AFTER DNA DAMAGE
1.1 Chk2 phosphorylation in normal cell lines
Human Chk2 protein, following modifications of the phosphorylation status, changes 
its electrophoretic mobility in western blot analysis (Brown et al., 1999; Matsuoka et al., 
1998). To test the kinetics of this event in a normal background I performed time-course 
western analysis on extracts from exponentially growing human cells before and after 4Gy 
of ionizing radiation. In four different cell lines, two normal lymphoblastoid (LCL-N1 and 
LCL-N2), a normal fibroblast (FB-N), and a breast cancer (MCF-7) with apparently 
normal ATM-dependent radiation response, the anti-Chk2 immunoreactive band present 
before irradiation, underwent a stepwise delay in electrophoretic mobility between 30min 
and 3hrs after treatment (Figure 11 A).
A detailed time-course analysis on LCL-N cells showed that Chk2 mobility 
maximally decreased between 1 and 3hrs post IR and remained apparently unchanged for 
up to lOhrs, thereafter the slow migrating Chk2 molecules decrease substantially to 
become undetectable at 72hrs (Figure 1 IB). As Chk2 electrophoretic retardation is due to 
phosphorylation since it can be eliminated by treatment with phosphatases (Matsuoka et 
al., 1998, and data not shown), these findings indicate that Chk2 is phosphorylated in more 
than one site, that the full phosphorylation takes place within lhr of irradiation and appears 
to involve most, if not all, Chk2 molecules. It should be underlined that the modifications 
of Chk2 phosphorylation detected in the early hours post irradiation were not due to cell 
cycle phase redistribution, as demonstrated through a flow cytofluorimetric analysis of 
single cells DNA content (data not shown).
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1.2 Role of ATM in Chk2 phosphorylation after ionizing radiation treatments:
analysis of AT patients and mutated ATM carriers
In budding and fission yeast the activation of Rad53 and Cdsl is dependent on the 
Mecl and Rad3, respectively (Brown et al., 1999; Chaturvedi et al., 1999; Matsuoka et al., 
1998). Considering that ATM and Chk2 are respectively the human homologs of 
Mecl/Rad3 and Rad53/Cdsl, I analysed the regulation of Chk2 in the lymphoblastoid AT- 
derived cell line AT52RM negative for ATM protein expression (Delia et al., 2000). In 
AT52RM, and in contrast to LCL-N cells, no Chk2 phosphorylation was seen at any time- 
points post IR (Figure 12), thus confirming previous results and validating the 
experimental conditions used here to detect ATM-dependent Chk2 phosphorylation 
changes.
In consideration of the high number of ATM mutation carriers (more than 1% of the 
total population) and the debate about the cellular defects and their predisposition to 
cancer, I assessed whether a reduced expression of ATM is sufficient to cause perturbation 
in Chk2 phosphorylation employing the AT-heterozygous cell line 227RM (ATM wt/mut), 
which exhibits 30% of the normal levels of ATM protein (Delia et al., 2000). The IR- 
induced phosphorylation of Chk2 in this cell line, analyzed as Chk2 mobility shift 
retardation, was comparable with normal cells (Figure 12); this observation was further 
confirmed in two others ATM heterozygous with less than 50% protein level (data not 
shown). These findings demonstrate that Chk2 is rapidly phosphorylated after 4Gy DNA 
damage in an ATM-dependent manner and even in ATM haploinsufficient background.
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1.3 NBSl-dependent Chk2 phosphorylation after DNA damage
1.3.1 Chk2 phosphorylation in NBS patients and mutated NBS1 carriers
The overlapping clinical and cellular abnormalities between AT and NBS prompted 
us to determine the impact of NBS 1 gene alterations on Chk2 regulation.
The NBS-derived lymphoblastoid cell lines 1548 and GM07078A, homozygous for 
two different truncating mutations of the NBS1 gene (Cerosaletti et al., 1998; Tupler et al., 
1997; Varon et al., 1998) were, unlike normal and AT cells, both negative for Nbsl full 
length protein (Figure 13A). 1548 cell line is derived from an Italian patient and shows a 
rare mutation (835del4), GM07078A is obtained from a Slavic patient and carries the most 
frequent NBS 1 mutation described (657del5) associated with a founder effect.
In these NBS cells, and in marked contrast to normal cells, no delay in the 
electrophoretic mobility of Chk2 (Figures 13B and 13C) was seen at any time points after 
IR, with the exception of a transient but modest shift at 3hrs which suggested that a small 
fraction of Chk2 molecules may have undergone a partial phosphorylation at this time 
point. These findings suggest that the phosphorylation of Chk2 is markedly impaired by 
Nbsl deficiency and emphasize the role of Nbsl for the rapid and sustained 
phosphorylation of Chk2.
As for ATM, two NBS carriers expressing >45% of the normal Nbsl levels (data not 
shown) had no defects in IR-induced Chk2 phosphorylation (Figure 13D), indicating that, 
like ATM, NBS1 haploinsufficiency plays no effect on Chk2 responses.
ATM phosphorylates preferentially serines and threonines followed by a glutamine. 
Clusters of SQ and TQ residues are present in many ATM targets (Abraham et al., 2001), 
including Chk2 which contains six such residues. The phosphorylation of one of these 
residues, T68, is an essential event for Chk2 activation (Ahn et al., 2000), although 
phosphorylation of other residues, eg: S33, S35 and SI9, provides a strong and sustained 
Chk2 activity (Buscemi et al., 2006). With the use of commercially available
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phosphospecific antibodies I confirmed the data obtained in western blot analyses by 
mobility shift assessment. Indeed, NBS cells revealed no detectable phosphorylation of 
S19 and S33/S35 in response to 4Gy IR, whereas phosphorylation of T68 was largely 
reduced (< 50%) compared to normal cells (Figure 14), thus confirming that Nbsl 
deficiency impairs Chk2 phosphorylation.
1.3.2 Chk2 phosphorylation in NBS cells complemented with normal or mutated 
forms of Nbsl
To verify that the defective Chk2 regulation in NBS cells was entirely due to Nbsl 
protein deficiency, and not to other additional defects present in the genetic background of 
these cell lines, I analysed Chk2 in NBS cells complemented with wild type NBS1.
For this approach I used fibroblasts (GM07166) derived from the same patient of 
GM07078, and SV40 transformed immortal NBS fibroblasts (ILB1), established from 
primary cells derived from a Polish patient, carrying the common Slavic founder mutation 
657del5. Both cell lines were stably transfected with an empty eukaryotic expression 
vector or with the same vector containing wt or mutated forms of the NBS 1 gene.
To further define the role of NBS 1 in Chk2 response, we analysed also NBS cells 
transfected with an NBS1 cDNA encoding a protein truncated at aa590 (GM07166/s590) 
that deletes the carboxy-terminus region containing the M rell binding domain (Tauchi et 
a l , 2001). We also tested an NBS1 mutant containing a serine-to-alanine substitution at 
position 343 (ILB1/S343A), a site directly phosphorylated by ATM immediately after 
DNA damage. Mutations in serine 343 are known to only partially complement the S- 
phase checkpoint in NBS cells (Gatei et al., 2000; Lim et al., 2000). Cell lines containing 
these constructs were obtained from Dr. Tauchi and Dr. Khanna laboratories. The western 
blot analysis of lysates obtained from GM07166 and ILB1 cell lines stably transfected 
verified that the ectopic wild type and mutants proteins were correctly expressed and 
showed the expected molecular sizes (Figure 14).
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The same mutants were also characterized for Nbsl, M rell and Chk2 proteins 
expression and localization by immunofluorescence of cytospin preparations to determine 
the relationship between NBS1 status, NBS 1-complex formation and Chk2 localization. 
NBS1 protein, undetectable in NBS cells (Figure 16, left panel, E-F), demonstrated a 
nuclear fluorescence both in normal (A, B) and NBS cells ectopically expressing wild type 
(C-D) or mutant s590 (G-H) and S343A (I-L) Nbsl proteins. M rell (Figure 15 middle 
panel) also shows a nuclear localization in normal (A-B) and NBS cells ectopically 
expressing wild type (C-D) or S343A NBS1 (I-L), whereas it is characterized by a diffuse, 
nuclear and cytoplasmic, fluorescence in NBS cells (E-F) and in NBS/s590 (G-H), the 
latter finding demonstrating that the C-terminus region of NBS 1 is essential for the nuclear 
localization of the NBS1/Mrell/Rad50 complex (as confirmed in Tauchi et al., 2001). 
Chk2 distribution in nuclear compartment that was detectable in normal cells was also 
retained in NBS cells, whether or not transfected with the various Nbsl mutants (Figure 16 
right panels). Likewise, the nuclear localization of Chk2 in these cells was unaffected by 
IR, even up to 8hrs after treatment (not shown). These unchanged nuclear distributions 
exclude a defect in Chk2 localization as the cause of its failed phosphorylation in NBS 
cells, and confirm the correct expression and localization of all the analyzed protein in 
NBS1 transfected cells.
Analysis of Chk2 protein in lysates obtained from NBS cells ectopically expressing 
wild type NBS1 (GM07166/NBS1 and ILB1/NBS1) showed, in contrast to that from 
parental or mock-transfected cells, a complete restoration of Chk2 phosphorylation in 
response to 4Gy IR (Figures 17A and B). Neither the C-terminus deletion mutant nor the 
S343 mutated NBS1 were able to efficiently complement the Chk2 phosphorylation defect 
(Figure 17C).
Since in NBS cells Chk2 phosphorylation is largely impaired and unsustained but can 
be complemented by a full length Nbsl I can conclude that this event is NB SI-dependent. 
Together with immunofluorescence data, the results obtained with the NBS1 mutants
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indicate that Chk2 phosphorylation is dependent on a nuclear localized, functional and 
ATM-phosphorylatable Nbs 1 -complex.
1.4 Nbsl-dependent Chk2 kinase activity.
To evaluate if Chk2 activity in addition to Chk2 phosphorylation was defective in 
cells from Nijmegen Breakage Syndrome patients, the catalytic activity of Chk2 was 
examined in vitro. I tested the incorporation of a radiolabelled phosphate in a fragment of 
Cdc25C containing the target residue Serine 216 in presence of Chk2 protein 
immunoprecipitated from normal and NBS cells extracts before, 30min and 3hrs after 4Gy 
of y-radiation.
In normal lymphoblastoid cells a slight basal activity of Chk2 was detectable in 
untreated cells but increased up to ~5fold at 3hrs but not at 30min after IR treatment 
(Figure 15A). Conversely, in NBS cells no increase in Chk2 kinase activity was observed 
at any time points after IR (Figure 18A). Western blots of the same reactions verified the 
presence of similar amounts of immunoprecipitated Chk2 protein (Figure 18A). 
Importantly, ectopic expression in NBS cells of wild type Nbsl restored the induction of 
Chk2 kinase activity in response to IR, to the same extent as in normal cells (Figure 18A). 
These results, in addition to those obtained by the mobility shift analysis, demonstrated 
that Nbsl is necessary for the phosphorylative activation of Chk2 by IR. Moreover, the 
finding that Chk2 activity does not increase in normal cells at 30min and in NBS cells at 
3hrs post IR (Figure 18B) in presence of a modest phosphorylation (Figure 11 A), suggests 
that the activation of Chk2 depends on multiple phosphorylation steps.
2. TREATMENT- AND DOSE-SPECIFICITY OF CHK2 PHOSPHORYLATION
It was previously reported that whereas low doses of IR activate Chk2 in an ATM- 
dependent manner, high doses of IR activate Chk2 independently of ATM. Furthermore is
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widely accepted that ATM activity is induced principally, if not exclusively, by damaging 
agents producing specific DNA lesions, that are double strand breaks. Therefore, I 
analyzed Chk2 phosphorylation in normal and NBS cells exposed to high doses of IR and 
DNA damaging agents that do not produce double strand breaks, in order to correlate Nbsl 
activity on Chk2 specifically with ATM.
2.1 Chk2 phosphorylation after high dose of IR.
I analyzed Chk2 phosphorylation in NBS cells exposed to 50Gy of IR in the attempt 
to determine the Nbsl dependence of this modification in response to extensive damage. In 
contrast to the findings observed after 4Gy of IR, the time-dependent phosphorylation of 
Chk2 in NBS and AT cells progressed as in normal lymphoblastoid cells LCL-N (Figure 
19), hence indicating that Chk2 activation becomes NB SI-independent other than ATM- 
independent following large scale DNA damage.
2.2 Chk2 phosphorylation after different genotoxic treatments.
Exposure of cells to UVC induces as primary damage the formation and 
accumulation of dipyrimidine photoproduct that mainly activate the NER pathway to repair 
DNA (for a review see Araujo and Wood, 1999). To investigate the role of Chk2 in 
response to these lesions, fibroblasts, were exposed to 10 J/m2 of UVC and examined for 
Chk2 modification. UV radiations are characterized by low energy and also a single cell 
can reduce the radiation received by the successive. This is the reason why fibroblasts, 
which grow in a monolayer, were chosen for this analysis. Compared to untreated controls, 
no Chk2 phosphorylation changes were detected in normal, AT and NBS cell lines at any 
time points after UV treatment (Figure 20A), despite the effectiveness of the dose used to 
elicit a DNA damage response as demonstrated by the ATM- and NBS-independent 
accumulation of p53 protein (Figure 20B).
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These findings would thus seem to exclude the activation of Chk2 in response to 
pyrimidine dimers formation, although this conclusion is in apparent contrast with other 
reports (Matsuoka et al., 1998; Tominaga et al., 1999). This discrepancy could be 
explained by the fact that previous studies were based on the use of much higher doses of 
UV (50-700 J/m ), that could induce DSBs and oxidative stress besides base modifications.
The genotoxic agent hydroxyurea (HU) rapidly inhibits ribonucleotide reductase and 
profoundly decreases purine pools, causing inhibition of replicative DNA synthesis and 
block of the replicative forks (Krakoff et al., 1968; Snyder, 1984). To investigate the effect 
of HU, the cells were incubated in ImM HU for 8, 16, 24 and 48hrs; and analysed for 
Chk2 status as well as for the cell cycle distribution using flow cytometry. No detectable 
changes in Chk2 electrophoretic mobility were found throughout the time course of HU 
treatment, except for a faint phosphorylation at 48hrs (Figure 21). The DNA flow 
cytometric analysis evidenced a cell cycle arrest in S-phase evident in normal NBS and AT 
cells at 24hrs (Figure 21), but not before this time point (data not shown), while at 48hrs a 
discrete amount of cells appeared dead (Figure 21). Thus, the finding that S-phase arrest 
induced by HU at 24hrs occurs without changes in Chk2 phosphorylation, would exclude 
the involvement of this kinase in the response to replication fork block.
3. DAMAGE SPECIFICITY OF CHK2 ACTIVATION
The differences detectable in Chk2 modifications after different sources of damage 
and following high doses of ionizing radiation prompted me to clarify the relation between 
ATM-Chk2 pathway activation and the amount and characteristics of the DNA lesions 
generated by genotoxic treatments. In particular, to correlate DNA backbone damage 
(single or double strand breaks) and ATM or Chk2 activation the first step was to evaluate 
in a sensitive approach the presence of DNA brakes. The role of other kind of lesions (i.e. 
pyrimidine dimers or arrested forks), already excluded by the absence of Chk2
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modifications following low doses of UV or HU treatments, was also further explored by 
the analysis of UV mimetic treated cells.
3.1 SSBs and DSBs estimation in IR and H?Q? treated cells
Two different techniques were used to evaluate the induction of single and double strand 
breaks, alkaline elution and y-H2AX immunopainting. Alkaline elution technique (AET) 
permits to discriminate SSBs and DSBs in the same sample evaluating the rate at which 
DNA strands are carried through a microporous filter by a fluid flow (Kohn et al., 1981). 
DSBs were, in addition, monitored through the analysis of phosphorylated H2AX (y- 
H2AX) nuclear foci in order to increase the sensitivity and the confidence with data 
obtained. Phosphorylated H2AX (y-H2AX) is essential to the efficient recognition and (or) 
repair of DNA double strand breaks (DSBs), and many molecules, often thousands, of 
H2AX become rapidly phosphorylated at the site of each nascent DSB, spanning 
megabases around. A specific antibody to y-H2AX reveals that this highly amplified 
process generates nuclear foci, and the number of these foci reflects that of DSBs 
(Rogakou et al., 1999).
In LCL-N cells, SSBs determined by AET increased with the dose of IR, but even at 
the lowest dose tested (0.25Gy) their amount was rather marked, accounting for a 
fragmentation index (FI) of 40% (Figure 22). DSBs, on the other hand, became detectable 
by AET at doses of IR >2Gy (FI: 8% at 2Gy) (Figure 22), and their yield increased in a 
dose-dependent manner. As expected, massive amounts of SSBs and DSBs (FI: 100%) 
were seen after 50Gy. The yields of SSBs and DSBs in irradiated AT52 and NBS cells 
were close to those of LCL-N receiving similar treatment (data not shown). AET analysis 
was also applied to hydrogen peroxide (H2O2) treatments, in order to evaluate the ATM- 
Chk2 response in relation to another agent that induces DNA breaks. Particularly H2O2 is 
known to produce in a dose dependent way both single and double strand breaks, but with 
a higher rate of SSBs than IR (Bimboim and Sandhu, 1997; Guidarelli et al., 1997).
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Extensive SSBs were seen in LCL-N cells exposed to 20pM and 100|xM H2O2 (FI: 50% 
and 100% respectively) (Figure 22), however DSBs were seen only in response to the latter 
concentration (FI: 40-60%) (Figure 22).
Although the AET is a useful technique enabling the quantification of both SSBs and 
DSBs from the same sample, its sensitivity limit doesn’t allow the detection of DSBs 
induced by <2Gy IR, estimated to be <60 breaks per diploid cell (Rogakou et al., 1999). 
As the average number of y-H2AX foci per cell well compares with the number of induced 
DSBs (Rogakou et al., 1999; Petersen et al., 2001; Rothkamm and Lobrich, 2003; Furuta 
et a l , 2003; Jakob et al., 2003), I quantified DSBs through the analysis of y-H2AX foci. In 
LCL-N, the y-H2AX foci per cells accounted for 2.8±0.9, but 5 min after irradiation with 
0.25Gy, 0.5Gy and lGy their number rose to 7.8±0.4, 13.6±0.8 and 19.9±1, respectively 
(Figure 23). LCL-N cells treated with 20pM and lOOpM H2O2 presented 6.9±0.5 and 
21.4±1 y-H2AX foci, respectively. By contrast, no y-H2AX nuclear foci were seen in 
response to 4-NQO, a UV-mimetic compound generating base modifications and 
secondary SSBs, but not DSBs (Brosh et al., 1999; Mirzayans et al., 1999), thus supporting 
the specificity of this technique for DSBs. The damaging activity of 4-NQO was confirmed 
by an ATM-independent accumulation of p53 protein (data not shown). Concordant with 
other studies (Rogakou et al., 1999), the foci per cell showed, in all samples, a Poisson 
distribution (data not shown). These data demonstrate that IR and H2O2 generate a dose- 
dependent number of DSBs, detectable even at the lowest doses tested (0.25Gy and 20pM 
H2O2), that are always accompanied by a preponderant amount of SSBs.
3.2 DSBs disappearance after DNA damage repair
DSBs repair in mammalian cells occurs as a two waves process, first a rapid 
response, within 1 hour, than a slow component, extending up to 24 hours, working on
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more complex lesions (Woods, 1981; Price et al., 2000). To further support my analysis on 
y-H2AX, I estimated the number of foci lhr after the exposure of cells to DNA damaging 
agents. When analyzed one hour after recovery from IR, the foci decreased to 
4±l(0.25Gy), 10+1 (0.5Gy) and 12±2.1 (lGy) (Figure 23), suggesting that at this time 
point not all lesions had been repaired (Nunez et al., 1995). Also the number of y-H2AX 
foci produced by H2O2 was markedly reduced lhour after recovery from treatment (Figure 
23), as a result of a repair activity.
To study the DSBs repair activity as function of the ATM-Chk2 pathway, I analyzed 
the y-H2AX foci in response to 0.25-lGy of IR in the ATM null cell line AT52 and in the 
Chk2 knock out cell line HCT116-Chk2-/-. In AT52RM (Figure 24A), the number of 
induced y-H2AX was comparable with those seen in LCL-N cells in response to similar 
doses of IR. However, lhr after recovery, the number of y-H2AX foci in AT52 had not 
declined, in contrast to what observed in LCL-N cells (Figure 24A), indicating a defective 
early DNA repair in the absence of ATM. In the HCT116 parental cells, the y-H2AX foci 
detected immediately after treatment (Figure 24B) were comparable with those in LCL-N 
cells and proportional to the dose of IR, and lhrs after recovery the number was 
diminished by 40% (Figure 24B) a value similar to that already shown in LCL-N cells, 
consistent with a DNA repair activity. Likewise, in HCT116-Chk2-/-, the number of foci 
before and after recovery were essentially the same as in the parental HCT116 cells (Figure 
24C), hence indicating that Chk2 deficiency does not alter the early DNA repair after low 
doses of IR in this cell line. Therefore in normal cells a first wave of DNA repair activity 
occurs within lhr of the damage, resulting in almost 50% reduction of detectable DSBs- 
associated y-H2AX foci, almost restoring the basal conditions in cells treated with 0.25Gy 
or 20pM H2O2 . This early repair is grossly impaired in ATM but not in Chk2 null cell lines 
in response to the induction of a limited amount of double strand breaks. This final
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observation is in accordance with the delayed activation of Chk2 detectable more than 1 
hour after the DNA damage occurrence.
3.3 IR dose dependent activation of ATM
Exposure of cells to radiation triggers ATM kinase activity, enabling it to 
phosphorylate several substrates involved in multiple cell cycle checkpoints (Shiloh, 
2003). The sensitivity, extent and speed of the ATM response were described as extremely 
high. Doses of irradiation that just cause two DSBs in a human cell activate the majority of 
ATM within minutes (Bakkenist and Kastan, 2003). I evaluated in LCL-N cells the in vitro 
and in vivo activity of ATM to determine its response to the initial amount of genomic 
damage. In vitro kinase assays were performed on cells harvested 30min and 3hrs after 
irradiation. At 30min, the basal activity of ATM increased in a IR-dose dependent manner 
starting from 0.25Gy and reaching a maximum of ~3fold increase in response to 2Gy or 
above (Figure 25A). However, at 3hrs no ATM activity was seen after 0.25 or 0.5Gy, 
whereas after 4Gy this activity was still elevated (Figure 25 A), hence suggesting that doses 
of IR between 0.25-0.5Gy elicit a transient activation of ATM. To verify this possibility, I 
analysed the autophosphorylation of ATM Seri981, an event reflecting the activation of 
ATM by DNA damage (Bakkenist and Kastan, 2003). Time-dependent analysis performed 
after 0.25 and 4Gy (Figure 25B) showed that the ATM pS1981 signal, whereas after 
0.25Gy had increased 2.5 fold at 30min to drop to basal level at 3hrs, after 4Gy the signal 
increase at 30min was 5.0 fold and only slightly dropped at 3hrs (3.5 fold). These results, 
together with the in vitro kinase assays, indicate that while ATM is rapidly activated by 
very low levels of DNA breaks, only after the induction of a higher level of damage a 
significant residual ATM activity is detectable for an extended period after damage 
occurrence.
As an indication of the ATM activity in vivo, I assessed the phosphorylation of its 
target residues Nbsl-Ser343, Chk2-Thr68 and p53-Serl5 (Shiloh, 2003). Nbsl-Ser343 and
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Chk2-Thr68 phosphoresidues, examined on cytospin preparations by immunofluorescence 
staining (respectively Figure 26A and 26B), showed in LCL-N a localization in nuclear 
foci, whose basal number increased starting from 0.25Gy. In AT cells, the basal number of 
phosphorylated Nbsl-S343 and Chk2-Thr68 foci did not increase even after 4Gy IR 
(Figure 26A and B), concordant with an ATM-dependence of these events. The specificity 
of Chk2-Thr68 phosphorylation was confirmed on immunoblots of Chk2 
immunoprecipitated from untreated and treated cells (Figure 26C). As a third confirmation 
in LCL-N cells, the levels of p53-P-Serl5 at 30 min rose modestly after 0.25-1 Gy, but 
substantially after 2-4Gy (Figure 26D). The defective phosphorylation of p53-Serl5 in 
irradiated AT cells verified the ATM-dependence of this event (Figure 26D and data not 
shown).
Collectively, these findings show that the ATM kinase is triggered by IR doses as 
low as 0.25Gy, yet this activity becomes sustained above lGy, and thus in response to a 
substantial number of DSBs.
3.4 Chk2 phosphorylation and activation after increasing doses of IR
Since the phosphorylation and activation of Chk2 are largely dependent on ATM 
(Brown et al., 1999; Matsuoka et al., 2000, Buscemi et al., 2001), I examined these events 
as function of the amount of DNA damage. IR dose-dependence studies showed that the 
phosphorylation-related upward shift of Chk2, just detectable 3hr after 0.5Gy, was 
maximal after 2Gy (Figure 27A) and involved most of the Chk2 molecules. A similar 
Chk2 mobility shift was seen one hour after irradiation (data not shown). In vitro kinase 
assays on Chk2 immunoprecipitated from LCL-N cells to determine the correlation 
between mobility shift and enzymatic activity, showed an enhancement of the basal 
activity of Chk2 towards Cdc25C substrate only in response to lGy, but not to lower doses 
of IR (Figure 27B).
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As a measure of Chk2 activity in vivo, the autophosphorylation of Chk2-Thr387 
(Schwarz et al., 2003) was evaluated on immunoblots of Chk2 immunoprecipitates from 
LCL-N, AT and NBS cells with a phosphospecific antibody. In LCL-N (Figure 27C), a 
phospho-Thr387 signal became detectable after 0.5Gy, but not 0.25Gy, and markedly 
increased with the dose of IR (up to 14 fold after 4Gy). By contrast, the Chk2-Thr387 
phosphorylation was undetectable in irradiated AT and NBS cells (Figure 27C), 
concordant with the ATM- and Nbsl-dependence of this event.
As an additional indicator of Chk2 activity in vivo, I evaluated the CDK inhibitor 
p21wafl, whose radiation-induced expression depends on Chk2 (Hirao et al., 2000; Takai et 
al., 2002). In LCL-N cells, p21wafl protein was markedly induced at 3hrs only in response 
to doses >lGy, whereas in AT this induction was defective (Figure 28).
As Chk2 mediates DNA synthesis arrest in response to IR through the 
phosphorylation of Cdc25A (Falck et al., 2001), we analysed the radiation dose-dependent 
occurrence of this event using radiolabelled thymidine. In LCL-N cells the RDS detected 
(Figure 28), while unaffected by doses of IR between 0.25 and 0.5Gy, was slightly 
inhibited by lGy but significantly by higher doses. Conversely, in AT cells, no DNA 
synthesis inhibition was seen at every dose tested, while in NBS cells a partial inhibition is 
detectable only at 4Gy IR (Figure 28) in accordance with the defective S-phase checkpoint 
typical of these syndromes, which should be almost in part ascribed to Chk2 impaired 
activation. Altogether, these findings demonstrate that Chk2 becomes activated only in 
response to a threshold number of DSBs, below which it remains inactive despite its 
phosphorylation on Thr68 by ATM.
3.5 Chk2 response to hydrogen peroxide
The relationship between the DNA damage spectra and Chk2 responsiveness was 
further examined in cells exposed to sublethal concentrations of H2O2 , an oxidant which 
primarily generates SSBs (Bimboim and Sandhu, 1997; Guidarelli et al., 1997; and Figure
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1 A). In LCL-N, AT and NBS cells exposed to 20pM H2O2, the electrophoretic mobility of 
Chk2 remained unchanged for up to 2hrs, relative to untreated cells (Figure 29A). 
Conversely, a time-dependent Chk2 mobility delay in response to lOOpM H2O2 was seen 
in LCL-N, but not in AT or NBS cells (Figure 29A). The extent of this phosphorylation- 
related shift, abolished by phosphatase treatment (data not shown), was similar to that seen 
after treatment with 4Gy. No changes in the basal levels of Chk2 kinase activity in vitro 
were seen in LCL-N, AT or NBS cells after treatment with 20pM H2O2 , whereas after 
treatment with lOOpM H2O2 the kinase activity rose in LCL-N cells only (Figure 29B). To 
determine the effects of these treatments on ATM, its in vitro catalytic activity was 
examined in LCL-N cells. The results (Figure 29C) showed a slight increase in the basal 
levels of ATM activity in response to 20pM H2O2, and this activity increased further by 
treatment with lOOpM H2O2 . Regarding p21wafl, induced levels of this protein were seen in 
LCL-N cells after treatment with lOOpM, but not 20pM H2O2 (Figure 29D). The defective 
induction of p21wafl in AT cells (Figure 29D) underscored the ATM-dependence of this 
response. Together with the AET and y-H2AX foci findings these results demonstrate a 
DNA lesion-dependent activation of Chk2, whatever the nature of genotoxic agent, e.g.: IR 
or oxidative stress. Furthermore, Chk2 appears not significantly responsive to SSBs and 
nucleotide base modifications.
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FIGURE 11: Time-course analysis of Chk2 phosphorylation following exposure to 
low dose y-radiation. Western blots performed on exponentially growing LCL-N, LCL- 
N l, LCL-N2, FB-N normal cells and MCF7 breast cancer cells (A) and (B). Cells were 
harvested before or at the indicated time-points after 4 Gy of IR. Note the progressive 
increase in Chk2 retardation in the early hours post IR. In normal cells the mobility of 
Chk2 at 72hrs post IR is similar to that of untreated cells.
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FIGURE 12: Chk2 phosphorylation in AT and heterozygous AT cells. Western blots 
performed on exponentially growing AT52RM (ATM -/-) and 227RM (ATM +/- cells). 
Cells were harvested before or at the indicated time-points after 4 Gy of IR. In both cell 
lines the mobility shift is similar to that of normal cells.
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FIGURE 13: Nbsl protein expression and time-course analysis of Chk2 
phosphorylation in NBS cells. Western blots were performed on normal (LCL-N), AT 
(AT52RM), NBS (1548 and GM07078) and NBS-heterozygous (GM08036 and GM08037) 
cells harvested before or at the indicated time-points after 4Gy IR. In A, samples were 
tested for Nbsl and afterwards for P-actin, to normalize lanes for protein content. Note the 
absence of Nbsl protein in the two NBS cell lines. In B, C and D, samples were tested for 
Chk2. Note the absence of mobility shift 30min post IR in NBS cells, and normal Chk2
response in the NBS-heterozygous cells.
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FIGURE 14: Chk2 phosphorylations in response to IR in normal and NBS cells.
Phosphorylation at T68, S33/S35 and S19 were evaluated in LCL-N and NBS (1548) cell 
lines at 1 hr after IR treatment, using phosphospecific antibodies on immunoprecipitated
Chk2 protein.
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FIGURE 15: Nbsl expression in NBS transfected cells. Lysates from the fibroblast cell 
lines GM07166/NBS1, ILB1/NBS1, GM07166/s590 and ILB1/S343A were western 
analyzed for Nbsl to verify ectopic expression of the respective NBS1 cDNA constructs. 
Blots were reprobed for p-actin to normalize lanes for protein content.
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FIGURE 16: Nbsl, M re ll and Chk2 localization in NBS transfected cells. Normal 
fibroblasts (A-B), NBS (E-F) and NBS cells stably expressing full length NBS1 (C-D), 
carboxy-truncated NBS1 (s590) (G-H), or S343A NBS1 (I-L). The negative control for 
each antibody, tested on normal fibroblasts is shown (M, N). Green and blue color images 
refer to immunofluorescence labelling and DAPI nuclear DNA staining, respectively.
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FIGURE 17: Chk2 mobility shifts in transfected NBS cells. Exponentially growing 
normal (FB-N) and NBS (GM07166, ILBl/mock) fibroblasts (A), NBS fibroblasts 
ectopically expressing either full length NBS1 cDNA (GM07166/NBS1, ILB1/NBS1) (B), 
a C-terminus deletion (GM07166/s590) or a S343A mutation (ILB1/S343A) (C), were 
harvested before or at the indicated time-points after 4Gy of IR and examined on western
blots for Chk2.
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FIGURE 18: In vitro Chk2 kinase activity and autophosphorylation. Chk2 was 
immunoprecipitated from normal, NBS (GM07078, ILBl/mock) and NBS cells ectopically 
expressing wild type NBS1 (ILB1/NBS1) exposed or not to 4Gy y-irradiation. Kinase 
reactions were assayed against a GST-Cdc25C recombinant substrate containing Ser216, 
the Chk2 target residue. The reactions were separated by gel electrophoresis and, after 
autoradiography, immunoblotted for Chk2 to verify that equal amounts of 
immunoprecipitated protein were present in each sample (A). Chk2 autophosphorylation 
was examined in kinase reactions in the absence of target substrate (B). The graphs were 
obtained by the densitometric analysis of autoradigraphic bands, as described in Methods, 
from three independent experiments. The reported kinase values were normalized for 
immunoprecipitated Chk2 content in each lane.
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FIGURE 19: Chk2 mobility shifts in response to high doses of y-radiation. Normal, AT 
and NBS cells were harvested before or after exposure to 50Gy of y-radiation and western 
analysed for Chk2. Note the similar IR-induced Chk2 gel retardation in all cell lines, 
indicating an ATM- and NBS-independent Chk2 phosphorylation event.
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FIGURE 20: Chk2 mobility shift in response to UV irradiation. Normal, AT 
(18ATRM) and NBS (GM07116) fibroblast were irradiated with 10 J/m2 and harvested at 
the indicated time points (A). Chk2 mobility shift was absent in all samples. To confirm 
the induction of a damage p53 accumulation was used as a reporter of a DNA damage 
response. P53 accumulate after the treatments in normal AT and NBS cell lines (B).
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FIGURE 21: Chk2 regulation and cell cycle analysis after HU treatment. Cell, 
collected before or at the indicated times after exposure to ImM HU, were split into two 
aliquotes, one probed on western blots with antibodies to Chk2 (A), the other analysed 
flow cytofluorimetry (B) to determine the S-phase arrest after treatment. Histograms in 
bold refer to HU treatments. The arrow indicates the position of the G1 phase peak. 
Horizontal and vertical axis display the relative fluorescence intensity and cell number,
respectively.
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FIGURE 22: Assessment of DNA strand breaks by alkaline elution in response to y- 
rad and H2O2. Immediately after irradiation on ice or lhr after incubation with H2O2, the 
DNA from LCL-N cells was extracted and analysed by AET to quantitate SSBs and DSBs. 
The yield of these lesions is expressed as a fragmentation index, relative to untreated cells.
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FIGURE 23: Quantification of y-H2AX nuclear foci formation in response to y-rad 
and H2O2. LCL-N cells were untreated (0) or treated with the indicated doses of y-rad, 
4NQO, H2O2 and permitted to recover for 5min or lhr prior to harvesting, cytocentrifuged 
onto glass slides and labelled by indirect immunofluorescence with an anti-y-H2AX 
antibody. Nuclear foci were counted by fluorescence microscopy.
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FIGURE 24: Quantitation of y-H2AX foci in ATM-deficient, HCT116 and HCT116-
Chk2_/" cells. AT52, HCT116 and HCT116 Chk2 KO cell lines were stained by 
immunofluorescence with the phosphospecific antibody and scored for y-H2AX foci 5 min 
and lhr post-IR. The data obtained in a representative experiment were represented in
histograms.
100
3hrs0.5hrs
ATM
0.25 0.25 0 IR, Gy
ATM-pS1981 
P-actin 
Time, hrs
4.5
3.5
ooo\ 4.0Gy 
m —  0.25Gy
2.5
T im e,hrs0.5
FIGURE 25: IR  dose-dependent activation of ATM. The in vitro catalytic activity of 
ATM immunoprecipitated from LCL-N cells 30min and 3hrs (A) after irradiation was 
tested against the PHAS-I recombinant substrate. Following autoradiography, the reactions 
on gels were immunoblotted for ATM, to verify the amount of immunoprecipitated protein 
per sample. In (B), the time-dependent autophosphorylation of ATM-Serl981 in LCL-N 
cells in response to low dose (0.25Gy) and high dose (4Gy) IR was examined by 
immunoblotting using a phosphospecific antibody, p-actin normalized the protein loading 
per lane. The histogram at the bottom was obtained from the densitometric analysis of 
ATM phospho-Serl981 signals after normalization for P-actin (results are average of two
independent experiments).
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FIGURE 26: IR-induced phosphorylation of p53, Nbsl and Chk2. Nbsl-Ser343 (A) 
and Chk2-Thr68 (B) phosphoresidues were detected by immunofluorescence staining with 
phosphospecific antibodies in LCL-N and AT cells before (0) and 30min after IR. The 
number of nuclear foci per cell in representative experiments is depicted in the histograms. 
The phosphorylation of Chk2-Thr68 (C) was detected on Chk2 immunoprecipitated from 
LCL-N cells 30min after irradiation by immunoblot with a phosphospecific antibody (top). 
Blots were reprobed with an anti-Chk2 antibody, to verify the amount of 
immunoprecipitated Chk2 per lane (bottom). The phosphorylation of p53-Serl5 
phosphorylation was analysed by immunoblot (D) in LCL-N and AT cells 30min after 
irradiation. Reprobing for p-actin verified lanes for protein content.
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FIGURE 27: Chk2 mobility shift and catalytic activity after IR. Immunoblots for Chk2 
(A) were performed on exponentially growing LCL-N cells 3 hrs after exposure with 
escalating doses of IR. Note the progressive, phosphorylation-related upward shift of Chk2 
becoming apparent after irradiation with doses above lGy. In vitro Chk2 kinase assays (B) 
were performed on the same cell preparations using a GST-Cdc25C recombinant substrate. 
The kinase reactions were resolved by gel electrophoresis and, after autoradiography, 
immunoblotted for Chk2 to verify the amount of immunoprecipitated protein per sample 
(Chk2 mobility shift is not detectable using this electrophoresis condition). The 
autophosphorylation of Chk2-Thr387 (C) was detected on western blot with a 
phosphospecific antibody on Chk2 immunoprecipitated from cells 45min after irradiation.
The blot was reprobed with an anti-Chk2 to verify the amount of immunoprecipitated 
Chk2 per sample. The histogram below depicts the IR dose-dependent increase in Chk2- 
Thr387 phosphorylation, obtained by the densitometric analysis (+/- SD) of three
independent IP/WB experiments.
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FIGURE 28: IR dose-dependent p21wafl accumulation and radioresistant DNA 
synthesis. p21wafl protein level in LCL-N cells 3hrs after treatment with the indicated 
doses of IR (A, top). Time-course analysis of p21watl protein accumulation in normal and 
AT cells after 0.25 and 4Gy (A, bottom). In (C), the RDS was evaluated on cells 
radiolabelled with [14C] thymidine, irradiated and after 60min pulse labelled for 15min 
with [3H]thymidine, as described in Materials & Methods. The ratios of [3H] to [14C] 
c.p.m. (corrected for c.p.m. resulting from channel crossover) were a measure of DNA 
synthesis. Data are average (+/-SD) of three independent experiments.
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FIGURE 29: Chk2 mobility shift and activation after H2O2 treatments. Cells were 
harvested before, lhr or 2hrs after incubation with H2O2 . In (A) the immunoblot shows a 
phosphorylation-related upward shift of Chk2 only in normal LCL cells treated with 
lOOpM H2O2. In (B), Chk2 was immunoprecipitated and tested for kinase activity in vitro 
(see legend to Fig. 2). The relative levels of enzymatic activity per lane, determined by 
densitometric analysis, are depicted. The effect of H2O2 on ATM activity (C) was 
examined in an in vitro kinase assays on ATM immunoprecipitated from LCL-N cells 
harvested lhr after treatment with the oxidant. A lysate from irradiated cells was included 
as a positive control. In (D) time course analysis of p21watl protein accumulation in normal
and AT cells after 20 and 1 OOpM H2O2.
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DISCUSSION
Eukaryotic cells are under the constant attack of intrinsic and extrinsic genotoxic 
agents that potentially could induce damage to nuclear DNA. To avoid the catastrophic 
effects of these lesions on genomic patrimony cells evolved a complex network of 
pathways named “global DNA damage response” that arrests cells cycle progression to 
prevent DNA damage increase in number and complexity and to supply the time necessary 
to repair the lesions. Furthermore, in multicellular organism, in presence of extensive or 
unrepairable damage, cell is conducted to suicide (apoptosis) to prevent a cell from 
becoming cancerous and endangering the organism. The importance of the global DNA 
damage response for cells and organisms survival is underlined by the wide number and 
seriousness of syndromes caused by the impairment of this response and by the high 
incidence of cancer predisposition in the vast majority of these affections.
Mutations in ATM and NBS1 genes are responsible for Ataxia Telangiectasia and 
Nijmegen Breakage Syndrome, respectively, two disorders that share hypersensitivity to 
genotoxic agents, immunodeficiency and increased predisposition to cancer. ATM is a 
protein kinase which upon activation (Jeggo et al., 1998) phosphorylates several target 
proteins (eg: p53, Chk2, Mdm2, RPA, BRCA1, c-Abl; Kastan and Lim, 2000) that are 
crucial for the regulation of checkpoint arrest and DNA repair (Lavin and Shiloh, 1997). 
Nbsl is a component of the multifunctional protein complex containing Mrel 1 and Rad50, 
involved in recognition and processing of DNA lesions (Pauli and Gellert, 1999; Petrini, 
1999). Several lines of evidence suggested a functional link between these proteins, 
including the common G2 checkpoint defect exhibited by the associated diseases (Beamish 
et al., 1996; Ito et al., 1999), the DNA-damage induced phosphorylation of Nbsl by ATM 
(Gatei et al., 2000), and their physical association in the BASC super complex (Wang et 
al., 2000).
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The protein kinase Chk2 is phosphorylated and activated in response to IR (Matsuoka 
et al., 2000), to further propagate the DNA damage signal along several pathways, causing 
cell-cycle arrest in the G l, S and G2/M phases; activation of DNA repair; and, in some 
cases, apoptosis (Falck et al., 2001; Chehab et al., 2000; Chaturvedi et al., 1999; Zhang et 
al., 2004; Chen et al., 2005). Chk2 could participates to the Gl/S arrest phosphorylating 
and regulating p53 and E2F-1 activation (Chehab et al., 2000; Rogoff et al., 2004) but also 
inducing Cdc25A degradation (Falck et al., 2001), while could blocks G2/M progression 
excluding Cdc25C from nucleus (Chaturvedi et al., 1999). Chk2 has been involved also in 
DSBs repair, a role carried out through the functional interaction with Brcal (Zhang et al., 
2004), and, as suggested by Chk2'/' mice and mouse embryo fibroblasts (MEFs), in 
apoptotic activation (Zhang et al., 2004).
The role of Chk2 as tumor suppressor was supposed for the involvement in the global 
checkpoint response and emphasized by the identification of germline and somatic 
mutations of the CHK2 gene in human hereditary and sporadic tumours (for a review see 
Bartek and Lukas, 2003).
As Chk2 is activated by phosphorylation directly by ATM, and in consideration of a 
possible functional interaction between ATM and Nbsl, I have examined the ATM- 
dependent DNA damage response pathway in relation to the role of Nbsl in the activation 
of Chk2, in the attempt to understand the molecular defects which characterize these two 
syndromes.
To finely describe Chk2 modification after damage and on the basis of the 
electrophoretic mobility changes on gels I have demonstrated a progressive time-dependent 
phosphorylation of Chk2 after IR, which becomes maximal between l-3hrs and persists for 
up to lOhrs. Given that Chk2 contains seven putative major phosphorylation sites, 
considered responsible for electrophoretic mobility delay after IR (Matsuoka et al., 1998; 
Melchionna et al., 2000) these findings suggest that these residues are not simultaneously 
modified. Recently I have obtained data supporting this hypothesis by the analysis of five
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phosphorylation sites which demonstrate different kinetics between in trans and 
autophosphorylation, the former occurring rapidly the second delayed in time after DNA 
damage (Buscemi et ah, 2006).
Chk2 phosphorylation after 4Gy IR was ATM and NBS 1-dependent, as it was found 
defective both in cells derived from AT and NBS patients. It should be noticed, however, 
that in NBS cells Chk2 showed a minor mobility shift at 3hrs post IR, suggesting that at 
this time-point a limited and transient phosphorylation may occur in a fraction of the Chk2 
pool of molecules. This partial change in Chk2 mobility could be explained by a low level 
of T68 phosphorylation, detectable in NBS cells. As in both normal and NBS cells Chk2 
revealed the same nuclear immunostaining pattern, I can exclude a mislocalization 
phenomenon as the cause for defective Chk2 phosphorylation in Nbsl deficient cells. I 
have also shown that decreased expression of ATM or Nbsl protein does not impair the 
phosphorylation of Chk2, according to the analysis on AT- or NBS-heterozygous cells. In 
presence of >40% protein level both for ATM or Nbsl a normal mobility shift is detectable 
in Chk2 protein. The normal behavior of AT-heterozygous cells is particularly intriguing 
since quite often other ATM-dependent events such as apoptosis or spindle checkpoint 
control, are compromised in these cells (Shigeta et al., 1999). AT heterozygous are 
estimated about 1% in population and up to now it is not clearly defined if they are 
predisposed to cancer occurrence or to other aspects of ATM disease.
As Chk2 phosphorylation leads to its enzymatic activation (Matsuoka et al., 1998), 
we assayed Chk2 kinase in vitro at different time points after IR. In these experiments, 
only the hyperphosphorylated form of Chk2 present in normal cells between l-3hrs 
showed enhanced kinase activity towards Cdc25C substrate, whereas the phosphorylated 
forms of Chk2 present in normal cells at 30min, and in NBS cells at 3hrs, showed basal 
activity only. Therefore, the Chk2-induced response to DNA damage in NBS cells is, like 
AT, completely defective and only a fully phosphorylated form of Chk2 is active on 
substrates.
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The presence of the same defect in two different NBS cell lines strongly suggest a 
direct relationship between impaired Chk2 activity and NBS1 deficiency, but to further 
provide evidence and to completely exclude the role of independent accumulating defects 
in NBS cell lines, I complemented these cells with a wild type copy of NBS 1 gene. I 
demonstrated that in this cell line Chk2 phosphorylation and kinase activity are both 
restored after IR. Noteworthy, Chk2 phosphorylation was neither restored by an Nbsl 
mutant protein truncated at amino acid 590, that deletes the Mre 11-binding domain 
(Tauchi et al., 2001), nor by a mutant in Ser343 (S434A), the ATM phosphorylation site 
on Nbsl. Mutants in Ser343 only partially complement S-phase checkpoint in NBS cells 
(Lim et al., 2000). Immunofluorescence data demonstrated a diffuse Mre 11 staining in 
cells transfected with truncated Nbsl (s590), in contrast to the nuclear Mre 11 staining of 
cells either normal or transfected with the wild type Nbsl, hence pointing out the essential 
function of the carboxy-portion of Nbsl for the nuclear localization of the Mrell/Rad50 
complex. Together with the other results on Chk2, these findings indicate that radiation- 
induced activation of Chk2 requires a correctly localized and phosphorylation-activated 
Nbsl-complex.
In S. cerevisiae, the activation of the Chk2-homologue Rad53 occurs by two 
interdependent steps, the first involving phosphorylation by Mecl (the homolog of human 
ATM), the second an autophosphorylation process (Pelliccioli et al., 1999). Evidences for 
the autophosphorylation of human Chk2 in vitro and in vivo by IR have been also provided 
(Lee and Chung, 2001). In this study, the IR-induced autophosphorylation of Chk2 in vitro 
was undetectable in AT compared to normal cells and partial in NBS cells. However in 
NBS cell lines at the time-point when Chk2 appeared modestly phosphorylated it was 
catalytic inactive against Cdc25C substrate (e.g.: at 30min and 3hrs post IR in normal and 
NBS cells, respectively). Hence, in the light of these findings, it is conceivable that in 
normal cells low doses of IR elicit an in trans phosphorylation of Chk2 by ATM and 
thereafter by other phosphorylation changes sustained by Nbsl. However we cannot
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exclude the participation of another kinase that may potentially cooperates with ATM in 
Chk2 phosphorylation.
Other works suggested that Chk2 activation was ATM dependent only in presence of 
a limited amount of damage but became independent from ATM protein in presence of 
extensive damage, induced by very high doses of IR (Matsuoka et al., 1998). To evaluate 
if, at these conditions, Chk2 activation became also Nbsl-independent we examined Chk2 
phosphorylation status in AT and NBS cells exposed to high doses of y-radiation (50Gy), 
demonstrating that it undergoes phosphorylation in a NBS- and ATM-independent manner. 
Whether this arises from the activity of ATR, an ATM-related protein kinase whose 
function partly overlaps with ATM, cannot be excluded. In this regard, it is worth noting 
that the closest human homologue of S. pombe Rad3, the modulator of the Chk2 
homologue Cdsl, is ATR (Bentley et al., 1996). In any case, the finding that ATM and 
NBS1 are either involved or not in the activation of Chk2, depending on the extent of DNA 
damage, agrees with a cooperative role of Nbsl and ATM in a DNA damage signal 
transduction pathway.
Collectively, my results support a model whereby the cooperation between ATM and 
NBS1 is an essential condition for the rapid and sustained activation of the checkpoint 
kinase Chk2 in response to low doses of IR DNA damage, thus providing an insight to 
better understand checkpoint defects in NBS cells. Recently some papers have shown a 
role for Nbsl as an enhancer of ATM activation and an essential adapter for the kinase 
activity of ATM on substrates (Dupre et al., 2006; Morales et al., 2005; Difilippantonio et 
al., 2005; You et al., 2005; Pauli and Lee, 2005), thus supporting the results described in 
this thesis. Furthermore I have demonstrated that a functional Nbsl complex is essential 
for a correct phosphorylation by ATM of low affinity phosphorylation sites in Chk2 
protein (Buscemi et al., 2006).
Among the different types of DNA lesions generated by the normal metabolism or 
exposure to genotoxic agents, DSBs are extremely harmful as they can lead, if unrepaired,
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to chromosomal breaks, rearrangements and tumor development (Khanna and Jackson, 
2001).
While many underlying biochemical and functional features of Chk2 have been 
disclosed in recent years, the precise nature of the DNA lesions that evoke the 
phosphorylative activation of Chk2 remain unclear, if not controversial. Studies in 
Xenopus demonstrate the activation of XChk2 by DNA oligonucleotides carrying double 
but not single strand ends (Guo et a l , 2000). Likewise, C. elegans Chk2 shows a key role 
in meiotic recombination (MacQueen and Villeneuve, 2001), a process involving the 
formation of DSB intermediates. However, human Chk2 seems responsive to UV or 
hydroxyurea (Brown et a l, 1999, Tominaga et a l , 1999), two agents that primarily cause 
pyrimidine dimers together with other bulky adducts and stalled replication forks, 
respectively, but that may induce DSBs at high doses and with extended treatments or as 
secondary events during the DNA repair process (Golos and Malec, 1991). In our hands 
the treatments of lymphoblastoid cells with ImM HU for 18 hours or the exposure to 10 
J/m2 UV irradiation activate a DNA damage response in an ATM independent way but did 
not induce a Chk2 mobility shift comparable with IR treatment. As we have demonstrated 
that only a completely shifted Chk2 protein is active on substrates, these data seem to 
underline the role for Chk2 in DSBs response as also suggested by its ATM and Nbsl- 
dependent activation. AT and NBS cells, which carry defects in these proteins, are in fact 
hypersensitive specifically to DSB-inducing agents (e.g.: y-rad) (Huo et al., 1994; 
Kraakman-van der Zwet et al., 1999). Moreover, AT and NBS patients show an 
immunodeficiency due to inappropriate resolution of DSBs associated with V(D)J and 
class switch recombination intermediates (Perkins et al., 2002; Petersen et al., 2001). 
While Chk2 activation in response to DSBs is a widely accepted event, the same activation 
after damaging agents like UV and HU seems more debated. Some papers have described a 
change in Chk2 mobility shift in response to UV or HU treatments (Matsuoka et al., 1998; 
Brown et al., 1999; Tominaga et al., 1999; Stiff et a l, 2006) although in any case only a
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partial and delayed in time modification has been detected. This discrepancy in part could 
be explained by differences in cell lines (primary, immortalized, tumor cells) or in 
genotoxic agents exposure concentration and time. Another source of variability should be 
the phase of cell cycle when damage occurs: in fact Chk2 has been described as 
phosphorylated in response to UV treatments specifically in S/G2 phase of the cycle (Stiff 
et al., 2006), while the cell lines used in this study were for 70-80% of the total population 
in G1 phase. The markers chosen to reveal Chk2 activation are another element of 
confusion. For example T68 phosphorylation or a partial mobility shift seems not 
indubitably correlate with a significant Chk2 kinase activity on substrates (Ahn and Prives,
2002). Particularly I found T68 phosphorylated in any case of DNA structure stress 
(Buscemi et al., 2006) including after cells transfection, this event not leading to Chk2 
activation or cell cycle arrest (data not shown). Recently I have also demonstrate the three 
ATM-dependent phosphorylation sites located in TQ/SQ region of Chk2 are not modified 
in response to UV or HU treatments (Buscemi et al., 2006), thus confirming a limited role 
of Chk2 in the cellular response to these agents.
The data obtained using different damaging agents prompt us to investigate the 
amount and characteristics of damage sufficient to activate a specific checkpoint response. 
This is particularly interesting not only for a more precise description of a molecular 
mechanism but also for the widespread application of DNA damaging agents as chemo- 
and radiation therapy in cancer. This is more relevant when radiosensitive patients, as AT 
and NBS are, should be treated for tumors occurrence.
To better understand the lesion-specificity of the Nbsl-ATM-Chk2 pathway I have 
examined the relationship between the spectrum and yield of inflicted DNA lesions and the 
activity of ATM and Chk2 kinases, to determine the threshold amount of initial damage 
capable of triggering an ATM-Chk2-dependent cell cycle checkpoint response. For this 
purpose, the DNA was extracted immediately after exposure of cells to genotoxic agents 
and analyzed by AET to estimate the yield of SSBs and DSBs (Kohn et al., 1981). This
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approach is useful because it can discriminate SSBs from DSBs but, as other existing 
techniques for measuring genomic DNA strand breaks, i.e. comet assay and pulsed-field 
gel electrophoresis, underestimates DSBs yields, due to sensitivity limits and non-random 
distribution of generated breaks (Prise et a l, 2001). I therefore evaluated DSBs on the 
same samples also by the detection of y-H2AX which rapidly accumulates (<5min) at the 
sites of DNA breaks to form foci (Rogakou et a l, 1999). Indeed in several studies, y- 
H2AX foci staining have been used as a sensitive marker for DSBs (Rogakou et a l, 1999; 
Petersen et a l, 2001; Rothkamm and Lobrich, 2003; Furuta et a l, 2003; Jakob et a l,
2003), the number of early y-H2AX foci well correlating with the number of DSBs 
inflicted.
By combining the results obtained by the AET with those derived from the 
assessment of y-H2AX foci, I have precisely estimated SSBs and DSBs induced by various 
treatments. I have shown that exposure of normal cells to 0.25-4Gy y-rad generates a dose- 
dependent increase in fragmented DNA, resulting primarily in SSBs at every dose tested. 
About 9 DSBs are induced by 0.25Gy IR and this number increase in a dose dependent 
manner.
As reactive oxygen species produced during mitochondrial respiration and 
peroxisomal metabolism are the major intracellular sources of DNA damage (Shackelford 
et a l, 2000), I analyzed the effect of increased intracellular free-radicals following 
treatment with H2O2 , an oxidant which primarily generates SSBs (Bimboim and Sandhu, 
1997; Guidarelli et a l, 1997). In LCL-N cells, treatment with 20 and IOOjiM H2O2 
generated, besides an extended level of SSBs, amounts of DSBs comparable with 0.25Gy 
and l-2Gy IR respectively.
To correlate DNA lesions yields and ATM-Chk2 pathway triggering I analyzed ATM 
and Chk2 activity in response to increasing doses of IR.
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To thoroughly assess the regulation of ATM I utilized an in vitro kinase assay and I 
detected by immunoblot or immunofluorescence the phosphorylation of p53 Seri5, Nbsl 
Ser343 and Chk2 Thr68, three well-established ATM targets (Shiloh, 2003). All the data 
obtained demonstrate that even a 0.25Gy exposure elicit in cells a rapid ATM respond, 
thus underlining the capacity of this kinase to sense and response to subtle DNA damages. 
Furthermore ATM induction is dose dependent and reaches a maximum at dose >2Gy, 
while at low doses (0.25-0.5Gy) the activity is unsustained up to 3hrs.
The ATM-dependent phosporylative activation of Chk2 leads to the phosphorylation 
of Cdc25A and Cdc25C, which are involved in S and G2-M phase checkpoints (Bartek and 
Lukas, 2003). Furthermore, Chk2'/' mouse cells also showed a significant impairment of 
p21wafl accumulation (Hirao et al., 2000; Takai et al., 2002), which may be attributable to a 
Chk2 activity on p53. Therefore collectively evaluating the in vitro and in vivo Chk2 
kinase activity and the Chk2-dependent events, p21wafl accumulation and S-phase arrest, I 
have shown that Chk2 activation is clearly detectable only at doses >lGy. Comparing data 
obtained form different approaches concur to define this threshold dose abrogating the 
specific sensitivity of each assay (i.e. antibody sensitivity).
Comparing these data with the DNA breaks evaluation at the same doses of IR I was 
able to demonstrate not only that Chk2 activity is unaffected by SSBs, that are present in 
large numbers after 0.25-0.5Gy, but also that a threshold level of DSBs is necessary to 
induce Chk2 kinase and Chk2 dependent downstream events. Furthermore our results 
reveal that despite the ATM-dependent phosphorylation of Chk2 in Thr68 (an essential 
activation site) occurs in response to y-rad dose as low as 0.25Gy, Chk2 activity is elicited 
in response to greater amounts of damage, demonstrating that this event is necessary but 
not sufficient for the complete activation of Chk2. In this regard, it is notable that other 
phosphorylation and autophosphorylation steps occur in vivo before Chk2 activation 
(Schwarz et a l, 2003). Particularly I have recently demonstrated that three newly 
identified Chk2 phosphorylation sites are modified only after doses of IR >lGy, thus
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correlating with the data described above (Buscemi et al., 2006). It is conceivable that 
some adaptors and/or other kinases more than ATM could contribute to Chk2 activation at 
higher doses of IR.
Whereas ATM is immediately activated by low number of DSBs (>9), Chk2 
activation is delayed (>0.5hrs) and requires a higher number of DSBs (>15). This kind of 
response is consistent with a role for ATM in damage repair (Shiloh, 2003) and in a rapid 
cell cycle arrest (Bakkenist and Kastan, 2003). On the contrary, the characteristics of Chk2 
induction seem more consistent with a role for this protein in checkpoint sustainment and 
apoptosis, as suggested by knock out mice (Jack et a l , 2002).
Furthermore the presence in normal proliferating cells of a constitutive number of 
DSBs (Fig. 2 and Rogakou et al., 1999) suggests that cells can cope with limiting amounts 
of DSBs by silently repairing them without enforcing cell cycle checkpoint arrests (Leroy 
et al., 2001). Therefore only DSBs resistant to a first wave of repair activity (Nunez et a l, 
1995; Wang et a l, 2001) could function as an activating signal for Chk2 pathway. This 
hypothesis is sustained by the absence of Chk2 activation at doses of genotoxic agents, 
0.25Gy and 20pM H2O2 , producing a damage rapidly and completely repaired, and could 
also explain the role of the repair complex Nbsl/Mre 11/Rad50 in Chk2 activation.
Regarding the response to SSBs, it is possible that they elicit an ATR/Chkl and/or 
DNA-PK-dependent response (Plumb et a l, 1999). Furthermore, if misrepaired, these 
primary lesions could lead to secondary lesions, e.g.: during DNA replication when a fork 
passing through a template that contains a SSB converts the lesion into a DSB. This could 
explain the activation of a G2/M accumulation checkpoint detectable 24hrs after 0.25Gy 
(data not shown). On the contrary the analysis on normal cells showed a dose-dependent 
suppression of DNA replication, that became detectable in response to lGy, but not to 
lower doses (e.g.: 0.25-0.5Gy) which prevalently generate SSBs. These findings thus 
exclude a rapid and robust activation of the S-phase checkpoint by SSBs.
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Neither the mobility shifts nor the catalytic induction of Chk2 was detected in normal 
cells exposed to 20pM H2O2 , despite the marked presence of SSBs (and a low number of 
DSBs). However, treatment with lOOpM H2O2 , which generates a large amount of DSBs, 
elicits an ATM dependent response as evident by the catalytic activation of Chk2. These 
responses overlap those seen after 2-4Gy IR, treatments inducing similar yields of DSBs as 
lOOpM H2O2 . Altogether, these findings indicate that the Chk2 pathway is activated by 
DSBs, irrespective of the nature of the DNA damaging agent.
My work provides novel insight about the lesion and dose specificity of checkpoints 
triggering, revealing significant differences in ATM and Chk2 activation that could explain 
the different roles of this proteins in the DNA damage response. Furthermore the evidences 
obtained by the dose-response analysis for genotoxic agents may aid to enhance the 
efficacy of radiation and other DNA directed anticancer agents used to treat ATM and 
Chk2 defective tumours.
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